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CHAPTER ONE
BACKGROUND AND RELEVANCE

1.1

The Liver: Anatomy and Physiology Overview
The liver is the largest internal organ that weighs around 1.2-1.6 kg. It performs over than

500 metabolic functions that can be classified in three main categories: (1) secretion; e.g.
proteins like albumin, urea and bile, (2) storage; glycogen and fat, and (3) detoxification utilizing
the broad range of cytochrome P450 enzymes that hepatocytes have.
The liver consists of smaller hexagonal-shaped functional units named hepatic lobules. Each
lobule has a central vein which is the terminal of the hepatic venules, and at the corners the
portal triads which consist of a venule (branch of portal vein), an arteriole (branch of hepatic
artery), and a bile duct (Fig. 1). The liver is consider a very dense organ with hepatocytes
predominate in both number and volume [1]. The total number of hepatocytes in a rat weighing
400g is estimated to be 18.5 X 108; which is equivalent to 1.4 X105 per unit volume (mm3)[2].
The functional unit of the liver is called acinus (plural acini) (Fig. 1); it consists of ellipsoidal
mass of hepatocytes aligned around the hepatic arterioles and portal venules just as they
anastomose into sinusoids. Each acinus can be divided into three zones based on its proximity to
the arterial blood supply; where zone one represents the hepatocytes that are closest to the
arterioles and hence best oxygenated, while zone three refers to the hepatocytes that are farthest
from the arterioles and have the poorest supply of oxygen. Therefore, hepatocytes in zone one
are the first ones to be exposed to blood coming from GI system. In addition, and based on the
blood supply for each zone, each zone has its unique enzymatic system for detoxification
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purposes. The oxygen concentrations in the sinusoid are in the range from 25 mmHg
(perivenous) to 70mmHg (periportal) [3].

Figure 1: Functional unit of the liver. Hepatic lobules as hexagonal-shaped functional units (left) [4] .
Hepatic acini overlayed onto lobules in the diagram (right) [5].

The lobules mainly consist of one-cell-thick chords of hepatocytes forming canals that are
called “sinusoids” (Fig. 2A). Sinusoids are lined, along with the hepatocytes, with endothelial
cells, stellate cells and Kupffer cells. The blood flows in the sinusoids where plasma and proteins
can migrate through endothelial cells via a unique feature called fenestrations (100-150 nm) into
the Space of Disse. At this space, direct contact with the hepatocytes occurs and uptake of
nutrients and oxygen by the hepatocytes takes place. The uniqueness of hepatic environment
comes from the space of Disse as it lacks any continuous barriers and it is rich with different
types of basement membrane proteins (Fig. 2B).
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Figure 2: Human liver sinusoid. (A) Digital image (H&E staining) showing the hepatocytes organized in
one-cell-thick chords [6]. (B) Rat liver sinusoid SEM image (width of sinusoid is 5 µm) showing the
fenestrated endothelial cells (100 nm in diameter), the microvilli of hepatocytes and the space of Disse
[7].

1.2

Orthotopic Liver Transplantation and Other Solutions
Liver diseases can be resulted from hepatotoxicity; for example hepatotoxicity caused by

drug-induced liver injury (DILI). The manifests come in various forms: (1) functions
dysregulation, (2) injury to hepatic parenchyma, (3) cell replacement/necrosis, or (4) cancer.
Some examples of such injuries are: steatosis, fibrosis and cirrhosis and the result could lead to
“end-stage liver diseases” and the need for liver transplant.
According to the Organ Procurement and Transplantation Network (OPTN) - U.S.
Department of Health and Human Services, there are 15,428 candidates on the waiting list for a
liver transplantation as of January 4th, 2015[8]. The majority of eligible patients die while on the
waiting list because of the severe donor shortage. The estimated cost for such procedure is
$577,100 according to the United Network for Organ Sharing (UNOS), adding to that almost
$21,900 for annual follow-up and medications [9].
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Orthotopic Liver Transplantation (OLT) is still the only treatment for end-stage liver
diseases. Despite its therapeutic potential, the procedure is limited by: donor organ shortage, the
need for a life-long immunosuppressive therapy and very high cost (~$500,000). Temporary
liver support systems are meant to replace a greater spectrum of liver functions over a short
period of time (days to weeks) and may also serve as a bridge to OLT by allowing more time to
find a better match between donor and recipient or stabilize the patient prior to surgery. Various
non-biological approaches, such as hemodialysis, hemoperfusion, plasmapheresis and plasma
exchange, have had a limited success because of the insufficient replacement of the synthetic and
metabolic functions of the liver. Extracorporeal biological treatments, i.e. life support systems
that are analogous in concept to kidney dialysis machines, specifically designed for liver failure
patients, have shown some beneficial results but are difficult to implement in a clinical setting.
An example of extracorporeal system is the bioartificial liver system (BAL), in which hepatoma
cell lines or isolated hepatocytes are incorporated into a bioreactor and induced to perform the
hepatic functions by processing the blood or plasma of liver failure patients [10, 11]. Although
these systems are more complicated than the filtration and dialysis systems, they can offer the
biochemical and specific functions which are not offered by the no-cells systems. Table 1
summarizes some clinical trials for temporary extracorporeal liver support systems [10].
Hepatocyte transplantation offers the possibility of increasing the survival rate as it can
be used as a therapeutic tool. This is dependent upon the ability to re-assemble isolated
hepatocytes into a functional organ by allowing the use of organs which would be considered too
traumatized for whole liver transplants. However, such organs may be an adequate source of
healthy hepatocytes. Hepatocyte transplantation also has great potential for providing cures for a
variety of liver-based, metabolic diseases, e.g., treatment for glycogen storage disease
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type 1a [12], familial hypercholesterolemia [13] and Congenital hyperbilirubinemia (Crigler–
Najjar syndrome) [14].
Device

Cell Mass and
Source

Configuration

Whole Liver Perfusion
Whole pig, baboon or
human liver

Dialysis and Filtration
Systems
MARS (Teraklin AG,
Rostock, Germany)

Perfusate and
Treatment
Protocol

Trial Phase

Whole blood, 5 hours
median perfusion time,
most patients received 1
or 2 perfusions

I/II

I/II

Albumin-loaded
hemofilter, 60-kD cut-off

None

Whole blood, 12–132
hours

Liver Dialysis Unit
(HemoCleanse
Technologies, West
Layfayette, IN)

Hemodiabsorption across
5-kD cut-off cellulosic
membranes

None

Whole blood, 6
hours/day;
up to 5 days

Prometheus (Fresenius
Medical Care AG, Bad
Hornburg, Germany)

Hemofilter, 250-kD
cutoff, connected to two
absorber cartridges, in
series with conventional
dialyzer

None

Whole blood, up to 12
hours divided into 2
treatments over 2 days

Bioartificial Livers
HepatAssist (Circe
Biomedical, Lexington,
MA)

Hollow-fiber,
polysulphone, 0.15–
0.20 μm pore size

50 g cryopreserved primary
porcine hepatocytes on
microcarrier beads

Plasma, 6 hours/session;
up to 14 sessions

BLSS (Excorp Medical,
Oakdale, MN)

Hollow-fiber, cellulose
acetate, 100-kD cutoff

70–100 g primary porcine
hepatocytes

Whole blood, 12
hours/session; up to 2
sessions

ELAD (Vital Therapies,
La Jolla, CA)

Hollow-fiber, cellulose
acetate, 120-kD cutoff

100 g human hepatoblastous
CJA cells per cartridge,
up to 4 cartridges/device

Plasma, continuous up to
107 hours

II

AMC-BAL (Hep-Art
Medical Devices, B.V.,
Amsterdam,
The Netherlands)

Spirally wound,
nonwoven polyester
matrix, no membrane

70–150 g primary porcine
hepatocytes

Plasma, up to 18
hours/sessions up to 2
sessions

I

Radial-flow bioreactor
(Sant’Anna University
Hospital, Italy)

Radial-flow bioreactor

230 g primary porcine
hepatocytes

Plasma, 6–24 hour
treatments, mostly in one
session

I/II

LiverX-2000 (Algenix,
Inc., Minneapolis, MN

Cells embedded in
collagen matrix within
hollow-fibers

40 g primary porcine hepatocytes
per cartridge, 2 cartridges/device

Blood

I/II

Hybrid bioartificial liver
(Hepatobiliary Institute of
Nanjing University,
China)

Polysulfone hollow-fiber
cartridge with 100-kD
cut-off combined with
adsorption column

100 g primary
porcine
hepatocytes

Plasma, one 6-hour
treatment, except one
patient with 2 - 6 hour
treatments

FDA Approved

I

II/III

I/II

I

Table 1: Clinical Trials for Temporary Extracorporeal Liver Devices. ELAD, Extracorporeal liver assist device;
BLSS, bioartificial liver support system; AMC-BAL, Amsterdam bioartificial liver system; MARS, molecular
adsorbent recycling system; FDA, Food and Drug Administration.[10]
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CHAPTER TWO
CURRENT TREATMENTS AND RESEARCH IN HEPATIC TISSUE ENGINEERING

2.1

Main Challenges in the Hepatic Tissue Engineering Field
Primary hepatocytes lose their functions and their specific phenotype when removed

from their environment [15]. They are highly dependent on the cell-cell contact and attachment
to the extracellular matrix (ECM)[16]. Therefore, when trying to culture hepatocytes in vitro, one
should take in consideration the followings: 1) the material used as extracellular matrix [17] , 2)
co-culture with non-parenchymal cells [18], and 3) the use of growth factors [19]. The main
obstacles to success are closely tied to the high metabolic rate of hepatocytes and the associated
limitations in oxygen and nutrient transport especially during cell attachment and adaptation to a
new environment. Recent published data suggest that dynamic perfusion of culture medium
through three dimensional scaffolds using bioreactors promote new tissue formation and
enhances hepatic functions [10, 11, 20, 21]. Each of these factors will be discussed in the
following paragraphs of this chapter.

2.2

The Extracellular Matrix (ECM) Materials
The main function of extracellular matrix is to provide tissues with their specific

mechanical and biochemical properties. Different cell types that reside in that ECM space are
responsible for its synthesis and maintenance, while ECM, in turn, also has an important impact
on cellular functions.
Cell–matrix interactions play a dominant role in cell attachment and migration, as well as
regulating and promoting cellular differentiation and gene expression levels. These specific
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functions are thought to be mediated by cell specific-receptors and cell binding epitopes on many
matrix molecules [22].
Various studies have been done on different materials in order to mimic the extracellular
matrix, where cells adhere and proliferate. Some of the materials investigated in this field are:
poly-L-lactic acid (PLLA), poly (D, L-lactide-co-glycolide) (PLGA), poly(ethylene glycol)
(PEG) and polyethylene terephthalate (PET) [23]. Non- polycarbonate materials also was used,
for example, the commercially available self-assembling peptide PuraMatrix®. This material is a
fully synthetic and resorbable hydrogel composed of repeating amino acid sequences of
Arginine-Alanine-Aspartic Acid-Alanine prepared in an aqueous solution. PuraMatrix® selfassembles into nanofibers on a scale similar to the extracellular matrix when exposed to
physiological levels of salt, forming a flowable hydrogel. When hepatocytes were cultured in
PuraMatrix® nanoscaffolds, they were able to synthesize albumin and secrete urea for up to 90
days of culture [24]. Regarding hepatocytes cultured in bioreactors, the major obstacle is to keep
them attached while perfusing the medium and sustain the shear stress [25].
Primarily, chitosan and collagen have been studied extensively as they are biocompatible
and enhance attachment and proliferation for many types of cells like hepatocytes [26-29]. Dunn
et al. [28] were able to maintain hepatic specific functions (secretion of albumin, transfirin,
fibrinogen, bile acids and urea) for more than 6 weeks in vitro. They cultured primary rat
hepatocytes in a sandwich configuration; consisting of two layers of hydrated type I collagen
prepared from rat tail tendons. This sandwich configuration successfully maintained the cellular
polarity normally found in the liver. In contrast, cells cultured on a single layer of collagen gel
failed to maintain hepatic functions.
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2.2.1

Chitosan
Chitosan is derived from chitin (naturally found in the arthropod exoskeletons) by

deacetylation in different degrees ranging between 50% and 90% (Fig. 3). It is considered
biocompatible; as it evokes minimal foreign body reaction, and biodegradable; as implants made
of chitosan are hydrolyzed by lysozyme-mediated activity. The degradation rate is inversely
proportional to the degree of crystallinity [30]. It has been found that after four hours of
incubation time of 50% acetylated chitosan with lysozyme in 0.1 molar phosphate buffer at pH
5.5 and 37°C , the chitosan solution lost 66% of its viscosity which indicated sufficient
degradation of it [31, 32]. Due to its (above mentioned) natural properties, chitosan is utilized in
research involving implantable applications in many fields such as orthopedic/periodontal, tissue
engineering, wound healing and drug/gene delivery [33].

Figure 3: Chitosan molecular structure [30].

Chu et al.[27] extensively studied the effects of chitosan nanofiber scaffolds on
hepatocyte cells viability, attachment and hepatic functions. They have showed that chitosan
nanofibers promote hepatocytes adhesion, albumin secretion, urea synthesis, cytochrome
P4501A1 enzymatic activity and glycogen synthesis compared to control. The cytotoxicity assay
for lactate dehydrogenase (LDH) and tumor necrosis factor α (TNF-α inflammatory cytokine)
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releases suggested that chitosan nanofibers have no effect compared to the control. On the other
hand, Jiankang et al. [34] prepared porous and well-organized (with hepatic chambers and
channel network) scaffolds from chitosan that was cross linked with gelatin. The scaffold has
pre-defined channels and chambers fabricated by freeze-drying then lyophilization. They seeded
these scaffolds with primary hepatocyte by shaking the 24-well plate that has the scaffolds
placed in. Their results showed that hepatocytes attached well to the chitosan-gelatin matrix and
they secreted albumin and urea during the first week of culture in higher amounts at the wellorganized scaffold compared to the porous scaffold.
Chitosan highly- porous scaffolds can be made by controlling the rate of solution
freezing, which in turn controls the direction of the thermal gradient. Such scaffolds have large
surface-to-volume ratio which enhances hepatocyte attachment and angiogenesis. Chitosan is
considered a biologically active material due to the presence of amine group and alcohol group
in its chemical structure. This cationic nature allows ionic and covalent interactions with other
materials like glycosaminoglycans (GAGs) and Proteoglycans (PGs) [30]. Scientists used this
unique property to complex different materials into chitosan scaffolds. T. Bou-Akl [35] in her
dissertation, showed that hepatocytes tend to form spheroids (with increase in size over time)
when seeded on chitosan membranes. The membranes were modified with GAGs such as:
heparin, heparan sulfate, dermatan sulfate and modified dextran. When hepatic functions were
evaluated, the highest rates for albumin secretion measured on heparin modified membranes.
However, urea secretion results showed lower amounts compared to the collagen gel sandwich
configuration (the control). When collagen was added to the modified chitosan membranes,
hepatocytes showed higher rates of spread and attachments, but lower albumin synthesis rates.
On the other hand, urea secretions increased as the amount of collagen increases, but yet it was
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in amounts lower than the control. She concluded that in terms of albumin synthesis, hepatocytes
in three dimensional configurations had better functions. While in terms of urea synthesis,
hepatocytes in two dimensional cultures performed better. This could be the result of the easier
accessibility to oxygen through diffusion from the medium to spread hepatocytes in monolayer
cultures. More attempts were made towards enhancing chitosan for better hepatic functions and
hepatocytes viability. Li et al. [26] investigated the effects of complexing chitosan scaffolds with
sodium alginate and heparin via ionic interactions, on hepatocytes morphology and metabolic
activities and they used chitosan membranes as control. Hepatocytes showed more attachment on
the modified scaffolds than the control and they were able to maintain their spherical
morphology with many microvilli on the cell membranes. Regarding albumin synthesis and urea
secretion; the highest rates were within the heparin modified chitosan. In general, modified
chitosan scaffolds maintained better hepatic functions than the unmodified chitosan. The
rationale was that hepatocytes synthesize different types of extracellular proteins which contain
GAGs integration sites on them. These sites allow the GAG molecules to bind and form such
away between the hepatocytes and the surrounding materials. Simiralry, with sodium alginate;
polyelectrolyte complexes were formed which played a significant role in maintaining
hepatocytes attachment and metabolic activities.

2.2.2

Glycosaminoglycans (GAGs)
Proteoglycans (PGs) are localized at the cell surface and in the extracellular matrix. They

are believed to have important roles in cell-cell interaction, cell growth and differentiation,
localization of bounded proteins to the cell surface and mediate cell functions. The biological
interactions mediated by PGs are believed to be due to the presence of the natural
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polysaccharides glycosaminoglycan (GAG) chains. Hence, GAGs are considered biocompatible
materials. Heparan sulfate (HS) and its highly sulfated form; heparin (HEP), are the most
abundant GAGs in the liver and they bind over 100 different proteins, including enzymes,
protease inhibitors, lipoproteins, growth factors, chemokines, extracellular matrix proteins,
receptor proteins and nuclear proteins [36-38].
GAGs bounded to chitosan scaffolds are expected to facilitate the binding and
organization of deposited extracellular matrix components to the implant. Consequently, this
process will enhance the integration of implant with existing tissue. As chitosan has the
positively charged amino groups; GAGs can be easily immobilized on it either ionically or
covalently due to their negative charge. The covalent immobilization of GAGs to chitosan can be
achieved by forming an amide bond between the carboxyl group and the amino group using the
zero-length cross-linker 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC);
a carboxyl activating agent for amide bonding with primary amines through the reaction
illustrated in figure 4 below [39].
Growth factors like fibroblast growth factor (FGF), hepatocyte growth factor (HGF),
vascular endothelial growth factor (VEGF) and heparin-binding epidermal growth factor (EGF)
are dependent on heparin for biological activity mediated through their high-affinity signaltransducing receptors [36].
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Figure 4: Covalent immobilization of GAGs to chitosan. Schematic representation of the amide bond
formation between chitosan (CHI) and GAG [39].

In view of the reported observations, for the present work, heparin has been chosen to
modify the chitosan scaffolds. It has been shown that heparin is used as anticoagulant factor as
well as a binding site for growth factors. In addition, heparin is able to stimulate some cell types’
proliferation like endothelial cells and dermal and epidermal cells as well as being useful for
culturing multiple cell types [38, 40, 41]. This choice is supported by our previous studies which
showed that chitosan modified with HEP has the best results among other GAGs tested (e.g.
dermatan sulfate and hyaluronic acid) in terms of enhancing hepatic functions and hepatocytes
viability for the reasons discussed above [35].
2.3

The Need to Re-create and Maintain the Polarized Plasma Membrane of

Hepatocytes
Epithelial cells express a special feature of cell membrane polarity which is needed in this
type of cells to provide a boundary between different extracellular components. This is achieved
by expressing specific lipids and proteins at each segment of the cell membrane; the apical
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domain that is in contact with the external environment, and the basal domain which faces the
blood circulation. These apical and basal domains are separated by tight junctions that
distinguish and maintain their specific lipids and protein composition and prevent any
intermixing. Distinctly, hepatocytes express special geometry where their apical domains at the
lateral membranes between two neighboring cells and forming the bile canalicular tubules. The
basolateral domains face the blood circulation and form the sinusoids (Fig. 5) [42]. Hence,
hepatocytes, as epithelial cells, need the basement membrane to be maintained to provide the
physical support and the polarity they require. The connective tissues beneath the basement
membrane secrete the necessary ECM elements to maintain its integrity.

Figure 5: Epithelial cell membrane polarity. (A) Schematic diagram illustrating the different plasma
membrane domains in epithelial cells in general. (B) Schematic showing the distinct polarized geometry
displayed by hepatocytes [42].

Maintaining the cell surface polarity in in vitro cultures is a complex and dynamic
process. It is greatly influenced by the cell-cell interaction, cell-extracellular interaction,
cytokines and growth factors. In addition, evidences suggest that cell-cell junction protein might
have alternate functions at other subcellular sites [43-46]. Comprehensive understanding of such
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parameters and interactions will lead to design of an in vitro model that aid to maintain this
polarization and help in preventing hepatocytes from de-differentiation. Unfortunately, freshly
isolated hepatocytes rapidly lose their polarity after the isolation. However, if they are cultured in
the collagen gel sandwich configuration, they can re-polarize in several days [28].

2.4

Co-Culture Systems and the Need for Three Dimensional Models
The adult liver consists of a complex multicellular structure (Fig. 6); which provides a

scaffold for many complex cell– cell interactions that allow for the effective and coordinated
liver specific functions [47, 48].

Differentiated Hepatocytes

Space of Disse
Sinusoid

Ito Cell

Figure 6: Liver sinusoid. Schematic diagram of the adult liver sinusoid which consists of: differentiated
hepatocytes, fenestrated endothelial cells, space of Disse, lipocytes (stellate or Ito cells), bile ductules,
and Kupffer cells [47].

It would be of great help in the field of liver tissue engineering to fully understand how
different cell types interact together in order to achieve the liver-specific functions and tissue
structure. When hepatocytes were grown on Matrigel (a gelatinous protein mixture derived from
mouse tumor cells, but it’s not a well-defined matrix) with pre-formed endothelial vascular
structures, Nahmias et al. [49] noticed that the hepatocytes migrated and adhered towards these
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structures and formed a new structure that resembled the in vivo sinusoids. These new structures
were able to retain stable cytochrome P450 gene expression and activity and stable albumin gene
expression and secretion rate for more than two months period of time. Nevertheless, it is still
poorly understood how heterotypic interactions facilitate the maintenance of differentiated
hepatocytes. Goulet et al. [43] noticed that microinjecting hepatocyes with Lucifer yellow CH
molecules caused a spreading of the dye to the neighboring hepatocytes. In those cultures,
hepatocytes were co-cultured with other non-parenchymal cells. On the other hand, this dye
spreading wasn’t observed in cultures where hepatocytes were cultured alone. The dye spreading
indicates formation of gap junctions between hepatocytes; which play significant role in
maintaining their phenotype and specific functionality, while no heterologous communication
was observed between hepatocytes and endothelial cells. They interpreted these results as due to
the fact that these two populations are separated by the space of Disse in the liver.
In liver tissue engineering, investigators should address problems involving
microvascular network formation in three dimensional cultures; which showed advantages over
the two dimensional ones by mimicking hepatic lobules and sinusoids and hence resulted in
better hepatic functional maintenance. The mechanism behind the actual organization of liver
sinusoids and how the endothelial vessels are coated with hepatic tissues has never been
achieved in vitro. Crucial elements that regulate hepatocytes viability and functionality are the
cell-cell interactions and the cell-substrate interactions while to success in developing a
functional tissue engineered solution the main obstacles to overcome are closely tied to the high
metabolic rate of hepatocytes and the associated limitations in oxygen and nutrient transport.
[50-52].
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It is well known that the ECM in the liver is similar in structure as other epithelial organs,
e.g. kidneys and lungs. The uniqueness of the hepatic ECM comes from the space of Disse where
it lacks of any continuous filtration barriers as the basement membrane and the endothelial cells
there has the fenestrations feature. This configuration is typical for the functions that this space
provides a bidirectional exchange passage for the molecules between hepatocytes and blood
stream for a distance that is < 1µm. It is also shown that collagen type I in the space of Disse
present as a network of cables while other types of collagen, e.g. type III and IV and fibronectin
present as discontinuous deposits around collagen fibers (Fig. 7) [53]. Table 2 summarizes the
potential of each cell type in the normal liver to secrete ECM components [54].

Figure 7: Different ECM components present in the space of Disse; Collagen Type I, Type III , Type IV
and Fibronectin (see legend for symbols representation) [53].
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Table 2: The potential of each cell type in the normal liver to secrete certain types of ECM components [54].

Histologically, every hepatocyte cell receives oxygen and nutrients by at least one
sinusoid. This vascular network is crucial to both the viability of the hepatocytes and the
detoxification of blood. Additionally, most of the hepatic non-parenchymal cells are located near
the sinusoids which make vascularization an important focus for further tissue engineering
studies.
Several studies investigated the co-culturing of different types of cells with primary
hepatocytes [51, 52, 55-57]. Their results indicated that hepatocyte viability and liver-specific
functions maintained stable over a culture period of several weeks in vitro. They used different
types of cells in their experiments, e.g. biliary epithelial cells, stellate cells, Kupffer cells as well
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as non-hepatic endothelial cells and fibroblasts [51, 52, 55-57]. Yamada et al. [58] , for example,
used lactone-modified Eudragit polymer that contains β-galactose residue; which can act as a
ligand of the asialoglycoprotein cell surface receptor expressed by hepatocytes. They mixed
equal numbers of hepatocytes and liver non- parenchymal cells and seeded them in tissue culture
dishes that were previously coated with the modified polymer. They noticed that hepatocytes
rapidly aggregated and formed spheroids and both albumin secretion and 7EC reduction rate
were increased by adding the non-parenchymal population compared with hepatocytes cultures
alone. In a different study, Sudo et al. [51] tried to approach the co-culture system from a
different angle. They tried to create a vascularized liver model by co-culturing primary rat
hepatocytes with human microvascular endothelial cells and with rat microvascular endothelial
cells in a three dimensional collagen scaffolds. The scaffold was located between two parallel
microfluidic chambers where the culture medium was allowed to perfuse through the scaffold
with a flow velocity of 27-35 µm/min (based on the physiological value 36 µm/min). In both cocultures, hepatocytes formed bile canalicular structures and were able to exhibit P450
cytochrome activity which indicates that they maintained their differentiated functions. Another
group who also investigated the co-culture systems Lu et al. [55]. They found that the liverspecific functions were significantly enhanced when primary rat hepatocyte spheroids were
cultured with NIH/3T3 mouse fibroblasts on galactosylated poly- vinylidene difluoride (PVDF)
compared with the hepatocyte spheroids cultured alone. They also found that this PVDF
substrate stimulated the hepatocytes to re-organize into spheroids with the fibroblasts coating
them which could mimic the liver regeneration. The reason for PVDF to stimulate the spheroid
formation was due to the presence of galactose ligands which interact with asialoglycoprotein
receptors on the hepatocytes membranes. In an interesting study by Abu-Absi et al. [56], it was
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revealed that when culturing primary rat hepatocytes with rat hepatic stellate cells, HSCs
proliferated rapidly and exhibited a morphology similar to fibroblasts. They were also able to
express some of the cytoskeletal proteins, e.g. α-SMA. This is the same scenario during in vivo
wound healing; the stellate cells get activated and start producing extracellular matrix proteins,
secreting growth factors and proliferating rapidly. The presence of the stellate cells had a
positive effect on albumin production. This co-culture system had effects on some liver-specific
gene expression, e.g. albumin, CYP2B1/2 and cyclophilin as their mRNA levels were higher
than the control.

2.5

Co-Culturing with Mesenchymal Stem Cells
A possible way to achieve the maintenance of basement membrane and the cell polarity is

co-culturing with mesenchymal stem cells (MSC). They present important advantages such as:
(1) easily isolated, (2) easily expanded in vitro, and (3) they are immunoprivileged and
immunomodulatory [59]. It has been indicated in the literature that MSCs act in paracrine
mechanisms as well as direct cell-cell contact as part of their role in immunomodulation in case
of liver injuries [60].
In addition, recent reports of experimental findings have revealed the hepatic differentiation
potential of MSCs for in vivo cultures (it is still unclear whether MSCs found in vivo or a type of
differentiated MSCs are involved in hepatocyte maintenance) [61]. This type of cells can provide
numbers of cues for hepatocyte development and growth (Fig. 8). For example, membraneassociated liver-regulating protein (LRP) is essential in maintaining the mature hepatocyte
phenotype and it is expressed by MSCs [62]. Another example is the Connexin-43 (gap-junction
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protein) that correlates with the capacity of fat-storing cell clones in maintaining hepatocytes
differentiated state and is expressed by MSCs as well [59].
It has been shown that MSC can deposit a mixture of ECM proteins such as collagen types I
& III, fibronectin, and laminin that are identical to those found in native liver [63].

Figure 8: Mechanisms of interaction between mesenchymal stem cells and hepatocytes [59]

In addition, MSCs can be differentiated into endothelial cells. Wang et al. demonstrated
the ability of murine embryonic mesenchymal progenitor cell line, C3H/10T1/2 to differentiate
into cells that express mature endothelial cell–specific markers such as CD31 and von
Willebrand factor [64]. This study used a parallel-plate system of fluid shear stress and
concluded that the shear stress significantly induces expression of mature endothelial cells
markers at both the mRNA and protein levels. Other researchers demonstrated this capability of
MSCs obtained from different tissue sources when vascular endothelial growth factor (VGEF)
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was added to the culture medium. Some examples of MSCs tissue sources are: umbilical cord
Wharton’s Jelly [65], porcine bone marrow [66], kidney [67], human bone marrow [68] and
human adipose tissue [69].
Mesenchymal stem cells have been thoroughly investigated in the past decade to be used
as potential treatments for acute liver failure and liver cirrhosis [60].

2.6

Porous Constructs and Dynamic Perfusion Systems
In vitro reconstruction of liver tissues is needed to enable the transplantation of tissue-

engineered organs. In addition, there is an increasing demand for in vitro models that capture
complex physiological and pathological events occurring in the liver [70]. Kasuya et al. [70]
established a tri-culture model using the main three cell types occupying the space of Disse in
their effort to mimic the natural environment for hepatocytes. The model consists of small
hepatocytes (SHs), hepatic stellate cells (HSCs) and bovine pulmonary microvascular endothelail
cells (ECs). SHs and HSCs formed organoids when cultured on microporous membranes were
HSCs penetrated the pores and were distributed to the top surface of the membrane as well as
between hepatocytes. After 14 days, ECs were seeded onto the top surface of the membrane and
hence forming an architecture that resembles space of Disse where HSCs are located between the
layers of hepatocytes and sinusoidal ECs. Their model was established in static conditions and
they didn’t evaluate the hepatic specific functions.
Dynamic perfusion systems have the advantage of producing an environment that mimics
the hepatic sinusoid flow circuit, facilitating a differentiated phenotype, enhancing neovascularization and elevating mass transport capacities [25]. Additionally, cultures under
continuous flow are more sensitive to hormone induced tissue function and have shown to
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improve viability, lifespan, metabolic output and in vivo-like cellular reorganization [11].
Designing bioreactor systems in order to improve mass transfer rates of nutrients and oxygen to
the seeded cells is required. It is also important in the process of removing metabolic wastes and
acidic degradation products from the biodegradable scaffolds. Chen et al. [71] were able to
culture primary hepatocytes within a galactosylated vegetable sponge in a packed-bed bioreactor
system. In this study, two flow rates for the medium flow were compared; 18 ml/min and 34
ml/min. They found that at higher flow rates, hepatocytes performed better in terms of albumin
and urea secretions over a culture period of one week and the reported rates were higher than
other reported rates in the literature for similar systems; high enough to be compared to the
normal rat liver secretion rates. They concluded that derivatization with galactose promoted cellpolymer and cell-cell interactions and enhanced differentiated state of the hepatocytes. Although
their results showed a promising approach, it was limited due to lack of system tests for longer
periods of time and in vivo studies. Also, their system doesn’t provide solutions for the
vasculogenesis issue for tissue engineered constructs. The major challenge yet to be solved in the
dynamic perfusion systems is how to provide protection from excessive shear forces which
hepatocytes may encounter; considering that this type of cells is a very sensitive type to very low
shear forces.

2.7

Commercially Available Liver Models for Drug Screening
The main hurdle in re-creating liver-like environment is that freshly isolated hepatocytes

have limited stability and the lack of hierarchy and structural components of the natural liver.
Some existing animal models that use liver slices can maintain the natural structure but they fail
to maintain the cell stability for long culture purposes. As it was mentioned before, monolayer
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cultures of primary hepatocytes in the collagen sandwich configuration are the most commonly
used format for toxicity assessment and provide a suitable model for initial assessment. They are
yet severely hindered by the lack of: (1) cell–cell interactions either via direct contact or via
paracrine effects, (2) 3D organization, and (3) non-parenchymal cells.
Nonetheless, freshly isolated primary hepatocytes continue to be the most relevant system
to study in vitro drug metabolism and hepatotoxicity and provide an initial assessment of drug
toxicity and enzyme function [72]. Figure 9 below summarizes six of the most recognized liver
models for these purposes. In Figure 9a is a schematic diagram for the RegeneMed® model; it
uses a transwell approach were non-parenchymal cells were seeded on a nylon screen sandwich
insert, stabilized for a week, and then hepatocytes were added to form 3D liver tissue. This
model uses near physiological ratio between hepatocytes and the non-parenchymal cells. Figure
9b illustrates the Insphero® model; hepatocytes were allowed to form 3D microtissue spheroids
using gravity enforced cellular assembly. In this model, hepatocytes and non-parenchymal cells
were introduced into a hanging drop in a specifically designed multiwell plate which forms a
microtissue spheroid in three days. Hepatopac® model (Fig. 9c) features a co-culture of
hepatocytes with fibroblasts. The hepatocytes were micropatterened in discrete islands in a 24well plate surrounded and stabilized by the stromal cells. Figure 9d represents CellAsic®
microfluidic liver sinusoid model. This model utilizes the lithography techniques to create an
artificial endothelial cell like barrier to mimic the porous liver sinusoid. This model is successful
in eliminating the need for endothelial cells and replacing them with a structural barrier which
shields hepatocytes from shear forces while still allowing nutrient exchange. Zyoxel® (Fig. 9e)
has the hepatocytes and non-parenchymal cells cultured in poly-carbonate scaffolds in multi-well
plate platform. The media will flow from the reservoir to the reactor chamber by pneumatic
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controlled underlay. The last example to mention here is the Hurel® approach (Fig. 9f); it is also
a microfluidic model that incorporates multiple tissues to interact in a physiologically based
pharmacokinetic model. This platform has the ability to accommodate multiple microfluidic
microscale cell culture units and connect them to media reservoir and a pump. [72]

Figure 9: Liver models. Summary of the most recognized liver models to study in vitro drug metabolism
and hepatotoxicity. [72]

2.8

Recent Hepatocyte Transplantation Research: Scaffold-less Approach
Because of the limitations on hepatocyte donors, researchers looked into using different

types of cells like hepatocyte progenitor cells and stem cells; they injected them as cell
suspensions at different injection sites. Injection site is very important to provide extracellular
matrix (ECM) for hepatocyte growth and differentiation. This approach is only valid in cases of
metabolic diseases and acute liver failure patients where the liver natural architecture is intact
and the requirement of homing is avoided. Some injection sites are the portal vein, the inferior
mesenteric vein and directly into the liver. It has been shown that the infused hepatocytes
dispersed with the host portal blood and translocated into the hepatic sinusoids. A disadvantage
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of this technique is that the infused cells were observed in central veins indicating an increased
risk of embolization to the lung. It remains an important issue of liver-directed cell therapy; the
localization and detection of the infused hepatocytes within the liver parenchyma of the host [73,
74] .
Takebe et al. [75] demonstrated a proof-of-concept of generating vascularized, functional
human liver from human induced pluripotent stem cells (iPSCs) liver buds. They first prepared
hepatic endoderm cells from human iPSCs by direct differentiation. The yield was about 80% of
the treated cells that expressed the hepatic marker HNF-4α. Then, they cultivated these cells with
human umbilical vein endothelial cells (HUVECs) and human mesenchymal stem cells. The
presumed human iPSC derived liver buds (iPSC-LBs) were mechanically stable and could be
manipulated physically and they have formed endothelial network. To test whether human iPSCLBs were capable of generating completely functional liver, the group transplanted them in a
cranial window model. These buds connected quickly with host vasculature within 48 h of
transplantation and formed vascular networks similar in density and morphology to those of
adult livers. Moreover, human blood vessels within the transplant became patent (unobstructed)
by connecting host vessels at the edge of the transplant. These human iPSC-LB transplants also
exhibited hepatic cord-like structures that are characteristic of adult liver after 60 days and were
able to produce albumin and metabolize drugs. This study demonstrated a proof-of-concept that
organ-bud transplantation offers an alternative approach to the generation of three-dimensionalvascularized organs. In view of this, more in vivo models should be evaluated to prove the
feasibility of this approach.
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CHAPTER THREE
HYPOTHESES AND SPECIFIC AIMS

Liver transplantation is considered the optimal treatment for end-stage liver diseases.
However, this is limited by the high demand for a matching donor which exceeds the
availability, the high cost for both the surgery and the annual follow-up, and the need for a lifetime immunosuppressant.

Current treatments based on non-biological approaches like

hemodialysis, hemoperfusion and plasma exchange have limited success in transforming this
disease from fatal into treatable disorder. These therapies did not replace the metabolic and
synthetic liver functions sufficiently. However, they provided more time for patients waiting for
liver transplant and stabilize their medical conditions. The extracorporeal biological approaches
such as cross dialysis and liver perfusion are hard to implement, but still provide sufficient
solution. In the past two decades, many works have been done toward hepatocyte transplantation
and hepatic tissue engineering. It is believed though that a hepatic mass of almost 10% (or even
less) [10, 76] of the human liver is able to normalize many hepatic disorders and metabolic
diseases. In this case, many liver patients could be treated with only one liver donor with
minimal invasive surgery and less cost. The ability to reliably re-assemble isolated hepatocytes
into a functional, “neo-organ” would greatly facilitate the development of such systems.
However, tissue engineering of sizable implantable liver systems is currently limited by the
difficulty of assembling three dimensional hepatocyte cultures of a useful size, while maintaining
full cell viability which is closely related to the high metabolic rate of hepatocytes.
The main objective of this project is to develop tissue scaffold designs using biologically
active materials and mesenchymal stem cell population for assembling isolated hepatocytes into
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a functional, vascularized mini organ. The proposed work is based on the following general
hypotheses: (A) hepatocytes in perfused porous scaffolds can produce an environment that
mimics the hepatic sinusoid with high mass transport capacities, (B) Co-culturing hepatocyte
cells with non-parenchymal cells; e.g. mesenchymal stem cells (MSCs) will limit hepatocyte
large aggregation in the short term and promote angiogenesis in the longer term as well as
shielding them against shear forces generated in the dynamic perfusion systems,

and (C)

Encapsulating hepatocytes with or without MSCs will protect them from excessive shear forces
they will be exposed to under dynamic perfusion conditions; and will provide sufficient cellECM contact signal that will maintain hepatocyte polarity in three dimensional cultures.
These hypotheses will be tested in the following proposed experiments in order to
develop systems for hepatocyte transplantation at a therapeutic level in vitro and in vivo. The
Specific Aims of the project are to:
1) Examine the effects of different scaffold designs and two cell seeding methods on
hepatocyte

distribution

and

viability

in

three

dimensional,

high-porous

chitosan/heparin perfused scaffolds. Optimization of cell seeding into three
dimensional scaffolds is a major challenge for hepatic tissue engineering. The seeding
method must be rapid to minimize the time that hepatocytes spend in suspension in order
to maintain their viability. It should also allow highly efficient cell entrapment to
maximize donor hepatocyte utilization. In addition, the seeded constructs should retain
enough space for perfusion in vitro or vascularization in vivo.
2) Evaluate the effects of co-culturing hepatocytes (HCs) with bone marrow
mesenchymal stem cells (BM-MSCs) on hepatocyte specific functions and examine
the effects of the seeding architecture on hepatocyte-MSCs organization and neo-
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tissue formation in-vitro. Recent reports of experimental findings have revealed the
hepatic differentiation potential of MSCs in vitro . In addition, MSCs can provide a
number of cues for hepatocyte growth and development .It is expected that co-culturing
hepatocytes with this specific type of cells will enhance hepatocyte viability and their
specific functions, as they will secrete and express certain proteins; connexin-43 and
membrane-associated liver-regulating protein (LRP) for example, which are essentials in
maintaining hepatocytes mature phenotypic state and their membrane polarity [59].
3) Evaluate the effects of encapsulating hepatocytes with or without bone marrow
mesenchymal stem cells (BM-MSCs) within chitosan-GAG fibers on hepatocyte
viability and metabolic performance under static and perfusion conditions.
Encapsulation will provide means of protection against shear forces under dynamic
perfusion conditions. In addition, it will provide means of the required barrier between
exogenous cells and the host immune system in the field of bioartifical-implantable
organs.
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CHAPTER FOUR
THE EFFECTS OF SCAFFOLD DESIGNS ON HEPATOCYTE DISTRIBUTION AND
VIABILITY IN THREE DIMENSIONAL, CHITOSAN/HEPARIN SCAFFOLDS

4.1

Introduction
Optimization of cell seeding into three dimensional scaffolds is a major challenge for

hepatic tissue engineering. The seeding method must be rapid to minimize the time that
hepatocytes spend in suspension in order to maintain their viability. It should also allow highly
efficient cell entrapment to maximize donor hepatocyte utilization. In addition, the seeded
constructs should retain enough space for perfusion in vitro or vascularization in vivo. Porous
scaffolds and dynamic perfusion systems can be designed to produce an environment that
mimics the flow architecture of hepatic sinusoids, and elevates mass transport capacities, while
facilitating efficient cell seeding. In this study, we compare two designs that aim to promote cell
seeding efficiency by effectively entrapping 100 million cells (~10% of a rat liver) by
maximizing either surface area for cell suspension inflow and subsequent perfusion culture, or
volume for cell entrapment. Particular pore architectures may also promote vasculogenesis upon
in vivo implantation if larger surface pores are available for vessel ingrowth.
The objective of this study was to modify the scaffold design developed by Dr.
Matthew’s group in previous studies, by changing the freezing methods used previously so that
the new design will have large pores at the periphery (~500 µm), and small pores at the central
(~10 – 20 µm). This new design will allow more vasculogenesis to the scaffold.
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4.2

Experimental Work

4.2.1

Materials
Medium molecular weight (MMW) chitosan from crab shells (molecular weight about

190- 310 KDa with 75 - 85% Deacetylated chitin), Trypan blue, FITC-conjugated secondary
antibody solution and heparin sodium porcine mucosa were purchased from Sigma-Aldrich (St.
Louis, MO). CellTracker™ Green CMFDA Dye was purchased from Life Technologies (by
Thermo Fisher Scientific Inc.). ZO-1 Rabbit polyclonal antibody and Rabbit anti-Connexin 32
were purchased from Invitrogen (by Thermo Fisher Scientific Inc.). All other chemicals and
solvents were of analytical reagent grade.

4.2.2

Collagen (Type I) Extraction from Rat Tail Tendons
Type I collagen was extracted following the protocols described by Rajan et al. [77] and

Elsdale et al. [78] with some modifications. Briefly, the tail was skinned first and then held by
two surgical clamps about 5 mm from its thinner extremity (8 tails were used in each extraction).
The collagen fibers (seen as white bundles) erre then pulled and collected in a beaker with
normal saline (0.9% NaCl) and then rinsed twice with deionized (DI) water. The tendons were
then moved to a beaker containing 3% acetic acid and stirred overnight at 4°C; at this point the
solution turned into more viscous one. The solution was then filtered through 4 layers of cheeseclothes and centrifuged at 12,000g for 2 hours at 4°C. The supernatant was collected carefully
into 2L beaker and the pellet was discarded. 30% NaCl (volume of 1/5 of supernatant volume
collected) was slowly dripped from a burette and the solution was allowed to sit without stirring
for 1 hour at 4°C. The solution then centrifuged at 4,000g for 30 min; pellets were collected and
rinsed with 5%NaCl-0.6%acetic acid. This step was repeated two times. The pellets were finally
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resuspended in 0.6% acetic acid and the solution was stirred for at least 48 hours at 4°C (or until
all clumps were dissolved). The solution then dialyzed (in dialysis bags with clamped ends)
against 1 mM HCl (10X volume), the 1mM HCl was replaced with fresh one every 4 hours for
five times. After that, the collagen solution was collected from the bags and centrifuged at
12,000g for 2 hours at 4°C. 3/1000 of total volume of chloroform then added for sterilization
purposes, the solution was stirred for 48 hours at 4°C with loosen cap. The collagen solution
concentration was determined by reading the optical density of a sample using
spectrophotometer at a wavelength of 280 nm. The OD then was divided by 0.09 to obtain the
concentration in mg/ml unit.

4.2.3

Hepatocyte Isolation and Culture in Collagen Gel Sandwich Configuration
Male, Sprague Dawley rat weighing 230 to 300 grams was used as cells donor.

Hepatocyte cells (HCs) were isolated using the two-step collagenase perfusion procedure
described by Seglen [79] and modified by Dunn et al. [28]. HCs viability and cell count were
determined by Trypan blue exclusion test and it was 90%. A single isolation typically yields 500
to 800 million hepatocytes with viability around >85% as indicated by Trypan Blue exclusion
test of cell viability. The collagen gel sandwich culture was used; in this configuration
hepatocyte cells were seeded onto collagen gel pre-coated culture dishes (1 million cells per 60mm tissue culture dish) and subsequently overlaid with a second layer of collagen gel after few
days of incubation at 37°C and 5% CO2 , the protocol suggested applying the second layer after
24 hours of incubation, but longer time was given to allow all dead cells to de-attach and
subsequently removed from the culture

[28]. The culture medium for HCs consisted of

Dulbecco's modified eagle medium (DMEM)- high glucose supplemented with 18.52 mg/L
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insulin, 7 mg/L glucagon, 7.5 mg/L hydrocortisone, 40 mg/L L-proline, 50 mg/L gentamicin ,
2.5 mg/L Fungizone, 10% fetal bovine serum and 10 ng/ml EGF [80] and it was changed every
day. The collagen gel sandwich configuration system was the control for all experiments in this
work.

4.2.4

Hepatocyte Membrane Polarization Assessment via Immunofluorescnece
Connexin 32 is a gap junction protein expressed in polarized hepatocytes that plays

important role in regulating signal transfer and growth control in the liver by constructing gap
junction channels and gap junctional intercellular communication [81]. ZO-1 is a tight junction
protein that is expressed in the plasma membrane of polarized epithelial cells and plays an
important role in sealing together the perimeters of polarized membrane and provides the
paracellular barrier necessary to maintain absorption, secretion, and transport [82]. The bile
canaliculi can be fluorescently labeled by using CellTracker™ Green CMFDA Dye; 5chloromethylfluorescein diacetate (CMFDA) is a fluorescent dye that stays in the cell cytosol
when hepatocytes are non-polarized and lack the canaliculi network, and is excreted into the bile
canaliculi network when it is formed by the polarized hepatocytes [83].
Hepatocytes in collagen gel sandwich were fixed with 10% formaldehyde, washed with
cold FBS three times and then incubated with 1% BSA/PBS w/v blocking solution at 4°C
overnight. Cultures were then incubated with primary antibody; either rabbit anti-Connexin 32
reactive for rat CX 32 or ZO-1 rabbit polyclonal antibody used as manufacturer directions. The
primary antibodies were washed away and a FITC-conjugated secondary antibody solution in
added and cultures were incubated overnight at 4°C. DAPI solution was added for nuclei staining
in blue color.
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CellTracker™ Green CMFDA Dye was applied following the manufacturer directions.
Briefly, the dye powder was dissolved in DMSO to make 10 mM stock solution then diluted with
serum free culture medium to make 25µM working solution. The hepatocytes in cell suspension
were incubated with pre-warmed working solution for 30 minutes in 15 ml centrifuge tube,
centrifuged at 300 rpm for 5 minutes, resuspended with fresh pre-warmed medium, and finally
seeded into the pre-coated culture dish with collagen gel.
Fluorescent images were taken using the phase contrast microscope and Nikon digital
camera.

4.2.5

Hepatocyte Metabolic Functions Assays (Albumin and Urea Secretion)
Metabolic performance of cultured hepatocytes was evaluated by measuring: (1) the rate

of albumin secretion via Enzyme-linked immunosorbent assay (ELISA) using antibody specific
to rat albumin and (2) the rate of urea secretion using diacetyl- monoxime colorimetric method
described by Rozet et al. [84] and. Sample collection and medium change was performed every
day for the whole period of cultures. These assays were performed in every experiment done in
this whole work.

4.2.6

Bulb-Shape Scaffold Fabrication, Cell Seeding and Cell Distribution Evaluation
Chitosan (1.5 wt% medium molecular weight 90% deacetylated) was dissolved in 0.2

molar acetic acid. Then liquid Nitrogen was perfused through a hollow stainless steel rod and
immersed in the chitosan solution (Fig. 10). This allowed the chitosan solution to freeze from the
inside towards the outside resulting in radially oriented pores with pore size of 20-50µm at the
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center and 500-800µm at the periphery. After freezing, the scaffold was lyophilized, neutralized
with 5% ammonia solution and then washed several times with phosphate buffer saline (PBS).

Figure 10: Scaffold fabrication. Schematic diagram of the scaffold fabrication setup.

To have an idea about how the cells were distributed inside the new scaffold
microstructure; fixed hepatocytes (in 10% formaldehyde solution) were seeded at a density of 3
million cells /ml using bioreactor setup (Fig. 11) with a peristaltic roller pump at a flow rate of 2
ml/min. As pores at the periphery were larger and got smaller towards the center, the direction of
flow was adjusted to be from the outside towards the center, where the cell suspension was
drawn into the inside of the scaffold core. The seeded scaffolds were then processed for
histology. Briefly, seeded scaffolds were fixed with 10% formaldehyde, dehydrated through a
series of graded alcohols (starting with 70% and finishing with 100%), cleared with Xylene
(three washes with final one lasts for 24 hrs), and embedded in liquid paraffin under vacuum.
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Eight micrometer thickness sections were obtained using the microtome, deparaffinized with
Xylene, and rehydrated through a series of graded alcohol (starting at 100% and finishing with
70%). Hematoxylin and Eosin stain (H&E) was applied to get an insight of cell distribution and
tissue structure using phase contrast microscopy and capturing digital color images with Nikon
digital camera.

Figure 11: Perfusion Bioreactor System.

4.2.7

Surface Freezing and Central Freezing Scaffolds Fabrication, Cell Seeding and Cell

Distribution Evaluation
The old design (surface freezing method) used in our group previously was obtained by
filling chitosan solution in annular stainless steel mold and immersing it in isopropanol/dry ice
bath allowing the inward radial growth of ice crystals from the surface into the central port (Fig.
12). The new proposed design (central freezing method) was made by filling chitosan solution in
the same annular stainless steel mold and then started freezing by perfusing liquid nitrogen
through the central channel. This technique allowed the outward radial growth of ice crystals
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from the rod into the solution (Fig. 12). The frozen masses were then lyophilized to remove all
water crystals leaving behind a network of interconnected microchannels. All scaffolds were
derivatized with pre-activated heparin with EDC for 24 hrs, washed three times with PBS to
remove excess heparin and incubated with FBS for 24 hrs prior to cells seeding to maximize
protein attachment adsorption on the pores’ surfaces. All washing steps were carried out in the
bioreactor system at flow rate of 5 ml/min.

Figure 12: Schematic diagram illustrating the fabrication method for the two scaffold’s designs

To estimate the seeding efficiency, the two designs then were seeded with the same cell
concentration (5 million cells /ml) as illustrated in Fig. 13. The surface frozen scaffold had the
flow directed from central port outwards the periphery and the central frozen scaffold had the
flow directed from outside towards the central port. Hepatocyte distribution inside the pores and
scaffold loading efficacy were examined by histology methods. The cell concentration used was
5 million cells /ml according to the results of our previous studies [35]. The results showed that
higher total cell number with lower seeding concentration yielded higher retention of cells with
more homogenous distribution inside the scaffold (i.e. 180 million cells at 5 million cells/ ml).
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Seeding time was set to 2 hours and the seeding efficiency was calculated by counting the
leftover cells that were not seeded during that time. Digital images from histology sections were
extrapolated using ImageJ® software to calculate the seeding efficiency based on the number of
cells counted in each image, the average volume per photo, and the total volume of the scaffold.

A

B

Figure 13: Bioreactor setup for seeding hepatocytes into the scaffolds. Schematic diagram illustrating
seeding methods for the two scaffold’s designs; (A) surface frozen, and (B) central frozen scaffolds.

4.2.8 Volumetric Flow Rate Calculations
The volumetric flow rate was calculated based on the physiological shear stress and
cross-sectional area available for flow for the empty pores for each design. A single pore was
assumed to be cylindrically shaped; for the surface frozen scaffold there were two different
layers of pore sizes; at outer surface and at inner surface. For the central frozen scaffold there
were three layers (Fig. 14).
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Figure 14: Pores architectures and dimensions. Schematic diagram illustrating the dimensions of all pores
in all layers for the two scaffold’s designs.

Physiological shear stress ranges between 0.5 Pa (at the sinusoids) up to 2 Pa (5 to 20
dyne/cm2) [85]. By choosing the lowest value τ = 5 dyne/cm2 and applying equation of continuity
for a cylinder, the volumetric flow rate in a single pore can be calculated using the following
formula:

6. .
=
. .
Where;
•

l : is the length of a given zone.

•

r : is the radius of a pore in a given zone.

•

µ : is the viscosity of the blood (~water) =10 dyne.sec/cm2.

•

V

•

: is the volumetric flow rate (cm3/min).

And the total number of pores at each layer can be calculated using the following:

#

=

2. . .
.
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Where;
•

L : is the length of the scaffold ( 1.0 cm).

•

R : is the radius of the scaffold at a given zone.
The volumetric flow rate for the surface frozen scaffold was calculated to be 1.8 ml/min for

the outer layer and 5.67 ml/min for the inner layer. And for the central frozen scaffold it was
1.2 ml/min for the outer layer, 6.0 ml/min for the middle layer and 0.05 ml/min for the inner
layer.
However, and based on oxygen requirements uptake for hepatocytes, the flow rate was
calculated using the basic mass transport equation [3, 86, 87]:

=

−

!#
"$

Where;
•

V : is max. O2 uptake = 0.38 nmol/s/106 cells.

•

k : is the solubility of oxygen in saline under 21% O2 and atmospheric pressure = 1.19
nmol/mL/mmHg.

•

Pi : is the measured partial pressure (mmHg) of oxygen in the inlet stream of the bioreactor.

•

Po :is the measured partial pressure (mmHg) of oxygen in the outlet stream of the bioreactor.

•

n : is the number of cells entrapped in the scaffold (100 million cells).

•

Q : is the volumetric flow rate (ml/min).
If Pi was set to be 158 mmHg (partial pressure of O2 at atmospheric pressure) and Po was

considered to be the typical physiological oxygen partial pressure found in the perivenous zone
(25–35 mmHg) [3], then the flow rate should be adjusted to 14.4 ml/min for future cultures to
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meet the oxygen requirements uptake for hepatocytes and hence they don’t suffer from hypoxia
inside the scaffolds.

4.3

Results

4.3.1

Hepatocyte Morphology and Metabolic Functions in the Collagen Gel Sandwich

Configuration
The hepatocytes formed a monolayer with a well-connected cellular network and bile
canaliculi formation between adjacent cells as seen under the phase contrast microscope (Fig. 15)
and when Green CMFDA CellTracker™ dye was used (Fig. 16). They expressed the gap
junction protein connexin 32 (Fig. 17) and the tight junction protein ZO-1 (Fig. 18); which
indicated that they were able to reconstruct the plasma membrane polarity in this configuration.

Figure 15: Phase contrast images for hepatocyte in collagen gel sandwich configuration culture.
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Figure 16: Green CMFDA CellTracker™ labeling. Fluorescent image of hepatocytes in collagen gel
sandwich system labeled with Green CMFDA CellTracker™ dye illustrating the formation of bile
canaliculi.

Figure 17: Gap junction Connexin32 labeling. Fluorescence image of hepatocytes in collagen gel
sandwich system labeled with anti-Connexin32 - FITC conjugated (green) illustrating the formation of
gap junctions between adjacent cells.
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Figure 18: Tight junction ZO-1 labeling. Fluorescent image of hepatocytes in collagen gel sandwich
system labeled with anti-ZO-1- FITC conjugated (green) illustrating the formation of tight junctions the
membranes of some cells.

Hepatocytes were able to synthesize albumin (Fig. 19A) and secrete urea (Fig. 19B) in
levels that match the reported ones in literature for the collagen gel sandwich static cultures [28].
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Figure 19: Metabolic assays of hepatocytes in collagen gel configuartion. (A) Albumin secretion for
hepatocyte culture in collagen gel sandwich configuration. (B) Urea secretion for the same cultures.
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4.3.2

Bulb-Shape Chitosan Scaffold Microstructure and Seeding Efficiency
Scanning electron microscopy was performed to evaluate the pore size of the new

proposed design and the microstructure architecture (Fig. 20). The pores were tapered- radially
oriented with larger diameters at the outer surface (D outer= 152.905 ±27.101µm), and small ones
at the inner surface (Dinner= 49.173 ± 11.071µm) as evaluated using SigmaScan Pro® software.
A

B

C

D
Periphery

Central port

Figure 20: Scanning electron microscopy images for the bulb-shape scaffold. (A) Periphery of the
scaffold (outer pores, view #3), (B) digital image of the actual scaffold where the numbers and connecting
lines represent cut sections of the scaffold and the white arrows represent directions of view, (C) inner
surface of the scaffold at central port (inner pores, view #2), and (D) cross sectional view of the scaffold
showing the radially oriented pores (large at periphery and smaller at center, view #1).

The size of the scaffold can be controlled by controlling the time of liquid nitrogen
perfusion. The desired size was estimated to be around 1.5 cm in diameter and 1.0 cm in length.
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This size was chosen as a reasonable one for transplanting the target cell quantity (100 million
hepatocytes ~10% of rat liver mass) into the peritoneal cavity of a rat weighing approximately
300 grams for in vivo studies. This number of hepatocytes was chosen based on the fact that a
rat of these species needs 12% to 23% of the whole liver mass to stabilize metabolic diseases
[76]. The seeded cells were more in number at the center of the scaffold compared to the
peripheries, but it seems that the central pores were blocked as seen in the histology images (Fig.
21).
One big challenge was encountered in this new design; the scaffold was collapsing due
to pressure drop inside the pores and central port during seeding. This maybe because the pores
were not successfully evacuated from air before starting seeding or they were blocked.
Modification to the fabrication method was applied; before immersing the metal rod in the
chitosan solution, liquid nitrogen was allowed to perfuse for few minutes to start the ice crystal
formation. This step was important to prevent the formation of thin sheet of chitosan around the
central port; which causes the pores to be closed at that site. However, this modification did not
yield successful results as expected as the collapsing issue was not resolved.

C

P

P

Figure 21: H&E histology images of seeded scaffold. The images show the cells condensed in the center
[C] and less at peripheries [P]. It also seems that the central pores were sealed with a thin layer of
material.
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4.3.3

Comparison between Two Scaffold Designs: Surface Freezing or Central Freezing
The directional freezing and lyophilization technique created highly porous structures

with tapered, radially-oriented pores (Fig. 22) with bigger pore diameter at the central port
(Dinner= 118.15 ± 55.27µm) and smaller pore diameter at the outer surface (D

outer=

21.35 ±

6.41µm) for the surface freezing method. For the central freezing methods the pores have larger
diameters at the middle (D
outer=

middle=

201.53 ±50.62µm), medium diameters at the outer surface (D

58.42 ± 14.14µm), and small ones at the inner surface (Dinner= 16.89 ± 7.71µm) as

estimated from the SEM images and using ImageJ® software.

Figure 22: SEM images of two designs. The images show tapered, radially-oriented pores in both
fabrication methods

The total volume of the surface frozen scaffold was 1.77 cm3 and for the central frozen
scaffold was 1.48 cm3. The seeding efficiency for the surface frozen scaffold was about 78%,
with a cell density of 44.1 X 106/ cm3. The seeding efficiency for the central frozen was about
65%, with a cell density of 43.9 X 106/ cm3. The predicted seeding efficiency using ImageJ®
software for the surface frozen scaffold was 99% and 68% for the central frozen one. The
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targeted number of total cells to be loaded to the scaffold was 100 million cells (~10% of rat
liver mass).
Histology images showed that the cells were distributed all along the cross sectional area
in the surface frozen scaffold (Fig. 23A), while in the central frozen scaffold many pores were
empty with cells more condensed at the center (Fig. 23B).

A

B
Figure 23: H&E staining images of cross sectional areas for seeded scaffolds. (A) Surface frozen
scaffold. (B) Central frozen scaffold.
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In yet another modification to the fabrication method to prevent scaffold collapse in the
central-freezing method, we adapted the following changes: (1) placing annealed chitosan fibers
(as they have high mechanical strength properties) at the center port to keep it open and (2)
placing a supportive nylon mesh at the center port. Despite this, the collapsing issue remained
unresolved as indicated by the collapse of the scaffold in radial direction, instead of axial.
Support to individual pores was needed to reinforce the whole scaffold, which might not be a
feasible option.

4.3.4

Metabolic Functions for Hepatocytes in the Surface Freezing Scaffold
In view of the challenges encountered in the central frozen design, the surface frozen

design was adapted for the all experiments hereafter in this project.
The chosen 1.8 ml/min flow rate was not sufficient to pull up the cells and circulate them,
so the seeding flow rate was changed to 5.6 ml/min. But after seeding, the flow rate was set back
to the 1.8 ml/min and the culture was run for five days. Scaffold cultured hepatocytes
synthesized albumin (Fig. 24A) and secreted urea (Fig. 24B) but at depressed rates compared to
hepatocytes in collagen-sandwich dish cultures, and rates declined with time.
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Figure 24: Metabolic functions for scaffold cultured hepatocyte in the surface frozen scaffold at 5.6
ml/min seeding flow rate and 1.8 ml/min culturing flow rate. (A) Albumin synthesis rate. (B) Urea
secretion rate.
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4.4

Discussion
To successfully design a three dimensional bioartifical liver, one should take into

consideration the cell source and the design of the three dimensional scaffold that will create
suitable environment for cells to attach and function. The challenges in the field of bioreactor
designs for 3D perfusion cultures are focused on the need to provide an appropriate scaffold for
tissue morphogenesis. The scaffold design must ensure relatively homogeneous distribution of
flow and mass transfer throughout the system. This was important in order to meet the metabolic
demands of the cells, as well as the physiological shear forces generated by such flow. In order
to achieve the desired cellular structure, hepatocytes must attach preferentially within the
pores/microchannels with sufficient strength to withstand both tissue remodeling forces and fluid
shear stress forces generated by in the perfusion system [88, 89].
Powers et al [89] suggests that in order to design a sufficient reactor perfusion systems;
tissue formation and cell behavior should not depend on the spatial arrangement or location of
channels within the microstructure of a given system. In addition, the system should approximate
the architectural properties and the perfusion conditions present in the natural hepatic tissue.
Here, we describe the design, fabrication methods, and flow rates calculations for
chitosan-heparin scaffolds. The scaffolds were highly porous with tapered, radially-oriented
pores and the pores architectures and dimensions can be controlled by controlling the freezing
direction to meet a desired design for a specific system. The microstructure of these highlyporous scaffolds provides large surfaces for cells to attach as well as facilitating nutrient and
oxygen transportation.
The flow rate of culture medium in the bioreactor was chosen to provide a physiological
range of fluid shear stresses within the pore geometry for the surface frozen scaffold design.
However, calculations based on hepatocyte oxygen uptake rates suggested that the operating
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flow rate (1.8 ml/min) was insufficient to meet hepatocyte oxygen requirements. In addition,
seeding with single cell suspensions may have resulted in uncontrolled cell aggregation and poor
oxygen and nutrient diffusion within the cell mass.
When Li et al [26] cultured primary rat hepatocyte into chitosan-alginate and chitosanheparin porous scaffolds, they didn’t expose the cells to any kind of flow and the hepatocytes
synthesized albumin and secreted urea at higher levels than hepatocytes in monolayer
configuration. This suggests that in our system, hepatocytes were exposed to high shear forces
that may have lead to cell death.

4.5

Conclusions and Future Work
•

With regards to central frozen scaffolds; many issues remain unsolved regarding scaffold
collapsing due to pressure drop in the pores during seeding process, so we adapted the
surface freezing method.

•

Seeding efficiency for surface frozen scaffold was higher than central frozen.

•

Operating at flow rate of 1.8 ml/min was insufficient to meet hepatocyte oxygen
requirements in the surface frozen design.

•

Seeding with single cell suspensions may have resulted in uncontrolled cell aggregation
and poor oxygen and nutrient diffusion within the cell mass.

•

Modifications to the perfusion system can be made to maintain the hepatic specific
functions in vitro; i.e. co-culture with non-parenchymal cells and encapsulation of growth
factors into the scaffold.
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CHAPTER FIVE
THE EFFECTS OF CELL SEEDING ARCHITECTURE ON HEPATOCYTE
DISTRIBUTION AND VIABILITY IN CHITOSAN/HEPARIN SCAFFOLDS

5.1

Introduction
In vitro assembly of functional liver tissue is needed to enable the transplantation of

tissue-engineered organs. In addition, there is an increasing demand for in vitro models that
replicate complex events occurring in the liver. It has been shown that hepatocytes in perfused
porous scaffolds can produce an environment that mimics the hepatic sinusoid with high mass
transport capacities [25]. Single cell suspensions of hepatocytes may not offer the appropriate
cell-cell interaction that is necessary to maintain hepatocyte survival and maintenance of
differentiated state. If seeded on non-adherent surface (or in 3D environment), hepatocytes will
spontaneously aggregate into spheroids that may exceed 400μm in diameter and hence develop
necrotic center. The advantages of culturing primary hepatocytes as spheroids can be
summarized as follows: (1) maintain the structural polarity of cells, (2) maintain the functional
bile canaliculi formation, and (3) maintain the differentiated functions of the hepatocytes.
Therefore, hepatocyte spheroids are expected to create an efficient 3D tissue models for hepatic
studies in vitro and can be used as the cell source in many therapeutic, diagnostic and discovery
applications as in case of developing bioartificial liver [90].
In the present study, we compared two seeding architectures; single cell suspension and preformed spheroids that aimed to promote cell seeding efficiency by effectively entrapping 100
million cells (~10% of a rat liver). Hence, spheroid size can be controlled to produce spheroids
of ~100μm in diameter (which will not develop necrotic center [91]) and then used those to seed
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the scaffold. It was shown previously that hepatocytes in aggregates can maintain viability and
functional integrity for months [92, 93].

5.2

Experimental Work

5.2.1

Materials
Lactate Dehydrogenase Activity (LDH) Kit was purchased from Sigma-Aldrich (St.

Louis, MO). AlamarBlue® Cell Viability Reagent was purchased from Invitrogen (by Thermo
Fisher Scientific Inc.). All other chemicals and solvents were of analytical reagent grade.

5.2.2

Seeding with Single Cell Suspension
The bioreactor setup, illustrated in figure 16 from previous chapter, was used to seed the

scaffolds with cell suspension (and later to perfuse the culture medium) using different seeding
setups. The target number of hepatocytes to be seeded was 100 million per one scaffold. Based
on the previous analysis and calculations, three seeding setups were performed to evaluate the
effects of seeding flow rate and culturing flow rate on hepatocytes metabolic performance and
neo-tissue formation and organization.
1. Setup #1: Circulating seeding at 37°C for 2 hours at flow rate of 5 ml/min and culture at
10 ml/min.
2. Setup #2: Circulating seeding at 37°C for 2 hours at flow rate of 20 ml/min and culture at
15 ml/min.
3. Setup #3: Repeated single-pass seeding at 4°C at flow rate of 20 ml/min and culture at 15
ml/min.
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5.2.3

Seeding with Pre-Formed Aggregates
Aggregates of primary hepatocytes were formed based on the intermittent settling

/agitation protocol described by Surapaneni et al. [94]. Briefly, 39 million hepatocytes were
suspended in 12 ml of hepatocyte culture medium and seeded into 75 cm2 culture flask (seeding
density of 520,000 cells/ cm2). The flasks were pre-coated with 10 ml of 2% bovine serum
albumin (BSA) in phosphate buffered saline (PBS) for at least 24 hrs prior to aggregation at
37°C. The flasks were then placed on a timed controlled linear shaker inside the incubator; 15
sec of mixing at 20 min intervals for 6 hours. This procedure produces spheroids of around
100µm in diameter as this size will not develop necrotic center. One hundred million cells were
used to form the aggregates and then seeded into the scaffold as described above using the same
three setups in the single cell suspension seeding.

5.2.4

Aggregation Efficiency Analysis and Aggregates Viability
Before seeding the scaffolds, samples of the aggregates were collected at three different

time point; 2 hours, 4 hours and 6 hours and fixed with 10% paraformaldehyde in PBS to
characterize the aggregation efficiency and the aggregates sizes. Images using phase contrast
microscopy were captured and analyzed using ImageJ® software. The software calculated the
areas of the particles (spheroids) in each image. From the areas, the volumes of the spheroids
were calculated and divided by the volume of a single hepatocyte with an average diameter of
20μm and considered to have a sphere shape (4188X10-6m3) to calculate how many cells were
available in each spheroid. SigmaPlot® software was then used to generate histograms of number
of cells in the spheroids vs. the spheroid count of that amount of cells in. From the histograms,
the aggregation efficiency can be estimated at each time point.
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To evaluate the viability of the spheroids, Trypan blue exclusion test was performed on
the samples collected (before fixing them) and images were captured with Nikon® color digital
camera. At least ten images were captured for each time point and the viability was evaluated by
counting blue cells and clear cells.

5.2.5

Histology Processing and Hematoxylin & Eosin Staining
To evaluate cell distribution within the scaffolds’ microstructure, scaffolds were fixed in

10% paraformaldehyde in PBS for 48 hrs and then processed for histology by embedding in
paraffin and cut into semi-thin transverse sections (8 µm) with a microtome. Then the sections
were washed with xylene to remove the paraffin. After that, Hematoxylin & Eosin stain (H&E)
was applied to distinguish cells from tissue structures using light microscopy. The distribution of
cells in the pores was analyzed using the transverse sections by quantitative image analysis of
digital light microscopy images.

5.2.6

Lactate Dehydrogenase Activity Assay
The LDH kit is commercially available from Sigma. The following description for the kit

is quoted from Sigma website: “Lactate dehydrogenase (LDH) is an oxidoreductase enzyme that
catalyzes the interconversion of pyruvate and lactate. Cells release LDH into the bloodstream
after tissue damage or red blood cell hemolysis. Since LDH is a fairly stable enzyme, it has been
widely used to evaluate the presence of damage and toxicity of tissue and cells. LDH is also
elevated in certain pathological conditions such as cancer. Quantification of LDH has a broad
range of applications. The LDH Activity Assay kit quantifies LDH activity in variety of
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biological samples. The assay is quick, convenient, and sensitive. In this kit, LDH reduces NAD
to NADH, which is specifically detected by colorimetric (450 nm) assay”[95].

5.2.7

AlamarBlue Viability Assay
AlamarBlue® is a proven cell viability indicator that uses the natural reducing power of

living cells to convert resazurin to the fluorescent molecule, resorufin. The active ingredient of
alamarBlue® (resazurin) is a nontoxic, cell permeable compound that is blue in color and
virtually nonfluorescent. Upon entering cells, resazurin is reduced to resorufin, which produces
very bright red fluorescence that is measured by a fluorescence spectrophotometer using
excitation wavelength of 560nm and emission wavelength of 590nm. Viable cells continuously
convert resazurin to resorufin, thereby generating a quantitative measure of viability and
cytotoxicity [96].

5.3

Results

5.3.1

Aggregation Efficiency and Aggregates Viability
Hepatocyte aggregates sizes increased as the time progressed. After six hours of

aggregation time, spheroids sizes started to grow bigger than the desired size (>100μm). Most of
spheroids had less than 25 cells after two hours of aggregation (Fig. 25A), between 25- 50
cells/spheroid after four hours (Fig. 25B), and between 25- 100 cells/spheroid after six hours
(Fig. 25C). The viability of spheroids was about 70% as tested by Trypan Blue exclusion
viability test (Fig. 25D).

55
A

After 2 hrs of Aggregation
250

After 4hrs of Aggregation

250

Spheroids Count

200

Spheroids Count

B

300

150

100

200

150

100

50
50

0

0

0

50

100

150

200

250

300

350

0

50

100

150

200

Cell Number in Shperoid

Cell Number in Shperoid

C

After 6hrs of Aggregation
100

D

Spheroids Count

80

60

40

20

0
0

50

100

150

Cell Number in Shperoid

Figure 25: Aggregation efficiency and viability. Histograms for aggregation efficiency after (A) two
hours, (B) four hours, and (C) six hours. (D) Digital color image of TrypanBlue cell health indicator
showing live cells/aggregates in clear color and dead cells/aggregates in blue color (viability ~70%).

5.3.2

Hepatocyte Metabolic Functions and Viability at Different Seeding/Culturing Flow

Rates and Temperatures
For setup #1 (circulating seeding at 37°C for 2 hours at flow rate of 5 ml/min and culture
at 10 ml/min) the observations are summarized in Table 3.
Single Cell Suspension

Pre-Formed Spheroid

Seeding Efficiency

70% (39.55 X 106 cells/cm3)

85% (48 X 106 cells/cm3)

Viability (LDH activity)

More stressed

Less stressed

Cell distribution within the
microstructure
Aggregates size at the end of
culture

Homogeneously distributed all At Center
over the cross section
Not much aggregates noticed 200-500µm
(mostly single cells)

Table 3: Summary of observations for setup #1: seeding flow rate 5 ml/min and culture at 10 ml/min at 37°C.
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Hepatocytes in both seeding architectures didn’t synthesize albumin for the whole period
of culture (Fig. 26). On the other hand, they were able to secrete urea (Fig. 26B) but at depressed
rates compared to the static collagen gel sandwich configuration; with no significant difference
between the two seeding architectures. LDH activity (Fig. 26C) was very high for scaffolds
seeded with cell suspension compared to those seeded with pre-formed aggregates.
Histology images showed that most of the cells remained as single cells when scaffolds
were seeded with single cells suspension at these flow rates (Fig. 27A), while cells remained in
aggregates and the aggregates increased in size (up to 500 µm) from the seeding size (100 µm)
which suggests that the spheroids fused together inside the pores. It was noticed that cells were
homogeneously distributed all over the cross section of the scaffold when cells were seeded as
single cell suspension, while they were concentrated at the center of the scaffold in the case of
seeding with pre-formed spheroids (Fig. 27B). However, a number of spheroids were lost during
the histology processing and were difficult to locate. In addition, more nucleoli were stained with
Hematoxylin in the pre-formed seeded scaffolds; which suggests they were viable at the fixation
time (Fig. 27A&B).
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Figure 26: Metabolic performance and viability of perfused, scaffold-seeded hepatocytes (A) albumin
secretion, (B) urea secretion and (C) LDH activity at seeding flow rate of 5 ml/min and culture flow rate
of 10 ml/min at 37°C.

A

B

Figure 27: H&E histology images of cross sectional areas for seeded scaffolds with (A) single cell
suspension and (B) pre-formed spheroids.
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From setup #2 we can conclude that seeding at flow rate of 5 ml/min and culturing at 10
ml/min were not sufficient to seed spheroids homogenously. In addition, culturing at 10 ml/min
didn’t provide the needed oxygenation.
For setup #2 (circulating seeding at 37°C for 2 hours at flow rate of 20 ml/min and
culture at 15 ml/min at 37°C) the observations are summarized in Table 4.
Single Cell Suspension

Pre-Formed Spheroid

Seeding Efficiency

70% (39.55 X 106 cells/cm3)

70% (39.55 X 106 cells/cm3)

Viability (LDH activity)

More stressed

Very stressed ( like cells in
suspension)

Cell distribution within the
microstructure

All along cross section

All along cross section

Aggregates size at the end of
culture

40-300µm
Mostly single cells, fewer
aggregates

40 -300 µm
Many single cells, mostly small
aggregates (70-100µm)

Table 4: Summary of observations for setup #2: seeding flow rate 20 ml/min and culture at 15 ml/min at 37°C.
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Albumin Synthesis
Rate (ug/hr/million cells)
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Figure 28: Metabolic performance of perfused, scaffold-seeded hepatocytes (A) albumin, (B) urea
secretion and (C) LDH activity at seeding flow rate of 20 ml/min and culture flow rate of 15 ml/min
seeding at 37°C.

Hepatocytes in both seeding architectures didn’t synthesize albumin for the whole period
of culture (Fig. 28A). On the other hand, they were able to secrete urea but at depressed rates
compared to the static collagen gel sandwich configuration; with no significant difference
between the two seeding architectures (Fig. 28B). It was noticed that the urea secretion rates at
these flow rates were higher than the ones from setup#1; where they fluctuated between two and
zero while at setup#2 they stayed above zero. LDH activity was very high for both seeding
architectures at these flow rates and seeding temperature of 37°C (Fig. 28C).
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From histology images, we noticed that the cells were homogeneously distributed all
along the cross sectional area in both seeding architectures (Fig. 29A&B). In the single cell
suspension seeding, cells remained mostly as single cells with very few aggregates of sizes 40300µm; the spheroids were seen attached at the walls of the pores by SEM (Fig. 30A). In the
case of pre-formed spheroids, some single cells were present but mostly there were small
aggregates (70-100µm) and some bigger aggregates (300µm) also seen attached and spread at the
walls of the pores (Fig. 30B). The nucleoli didn’t stain with hematoxylin which suggests that
most of the cells were dead at the end of the culture.
It is to be noted that in SEM photos the spheroids had rough surfaces with a lot of
materials around the cells. These materials might be cell debris from previously dead and
deteriorated cells; we can notice such debris in the histology images as well.

A

Figure 29: H&E histology images of cross sectional areas for seeded scaffolds with (A) single cell
suspension and (B) pre-formed spheroids.

B
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A

B

Figure 30: SEM photos of cross sectional areas for seeded scaffolds with (A) single cell suspension with
some small aggregates attached to the wall, and (B) pre-formed spheroids with bigger aggregates also
attached and spread at the walls.
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From setup #2 we can conclude that seeding at 37°C may have contributed to hepatocyte
death as their metabolic rate was high at this temperature. While seeding at flow rate of 20
ml/min was sufficient to seed both single cells suspension and spheroids homogenously, it may
have generated shear forces that were higher than the levels that hepatocytes can tolerate.
For setup #3 (repeated single-pass seeding at 4°C at flow rate of 20 ml/min and culture at
15 ml/min) the observations are summarized in Table 5.
Single Cell Suspension

Pre-Formed Spheroid

Seeding Efficiency

88% (49.7 X 106 cells/cm3)

92% (52 X 106 cells/cm3)

Viability (nuclei staining with
Hematoxylin)
Viability (LDH activity)

~50%

~10%

More stressed

Less stressed

Cell distribution within the
microstructure

All along cross section

Can’t be seen (all were at the
seeding port and got lost
during histology processing)

Aggregates size at the end of
culture

Big aggregates filling up the
pores.

Many single cells but mostly
aggregates of sizes 50 -200
µm.

Table 5: Summary of observations for setup #3: repeated single-pass seeding at 4°C at flow rate of 20 ml/min and
culture at 15 ml/min.

Hepatocytes seeded as a single cell suspension and cultured at flow rates of 15 ml/min
exhibited higher rates of albumin (Fig. 31A) and urea secretion (Fig. 31B) during the 12-day
culture period than hepatocytes seeded as pre-formed aggregates. The albumin rates were at
depressed rates compared to hepatocytes in control collagen-sandwich dish cultures but the urea
secretion rates were close to the control. LDH activity (Fig. 31C) was low for both seeding
architectures at seeding temperature of 4°C compared to the cells cultured in control collagen gel
sandwich configuration.
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Figure 31: Metabolic performance of perfused, scaffold-seeded hepatocytes (A) albumin synthesis, (B)
urea secretion and (C) LDH activity at seeding flow rate of 20 ml/min and culture flow rate of 15 ml/min
(seeding at 4°C)

AlamarBlue® cell health indicator assay (Fig. 32) shows that hepatocytes in the scaffold
seeded with pre-formed spheroids had very low activity, while those in the scaffold seeded with
single cell suspension had higher activity but still lower than the activity of cells in collagen gel
sandwich configuration or the static culture of pre-formed spheroids on chitosan-heparin
membranes.
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Figure 32: AlamarBlue® cell health indicator assay on day 11 of culture of hepatocyte in perfusion
cultures of suspension-seeded and pre-formed spheroid-seeded, hepatocytes in static collagen gel
sandwich configuration and preformed spheroids on chitosan-heparin membrane.

Histology sections showed that cells were distributed all along the pores in scaffold
seeded with single cell suspension (Fig. 33A). They were more concentrated at the central port of
the scaffold in the pre-formed aggregate seeding architecture (Fig. 33B and Fig. 34). It can be
noticed from the SEM photos (Fig. 35) that the aggregates were concentrated at the central port
forming one large aggregate. Also, cells were spread and attached to the walls of the pores and
blocking some of the central pores.
From setup #3 we can conclude that a flow rate of 20 ml/min was adequate for seeding a
cell suspension, it was too low to efficiently seed spheroids into the scaffolds. The spheroids
settled in the central port and did not distribute into pores, resulting in excessive spheroid
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aggregation, diffusion limitations, and cell death. Seeding flow rate of 20 ml/min and culturing at
15 ml/min may have resulted in hepatocyte damage and death due to high shear stress forces.
A

B

Figure 33: H&E histology images of seeded scaffolds with (A) single cell suspension (cross section) and
(B) pre-formed spheroids (longitudinal section).

Figure 34: H&E histology images of a longitudinal section of scaffold seeded with pre-formed
spheroids. Notice the large aggregates filling the central port.
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Figure 35: SEM photos of a longitudinal section at the center port of scaffold seeded with pre-formed
spheroids showing cells forming large aggregates and blocking the center pores.

5.4

Discussion
Hepatocytes will spontaneously aggregate into spheroids if seeded on non-adherent

surface or in 3D environment. The distribution of oxygen and metabolites in these organoids will
become critical issue as they are transported by means of diffusion that depends on cells uptake
and consumption of these elements, and their excretion to other elements. Hence, the size of
these spheroids should be controlled as large ones will have diffusional gradients that will limit
the supply of sufficient nutrients and the removal of waste at the heart of aggregates and thus the
cells at the center will eventually die [91]. In this work, we sought to control the size of the
aggregates by forming them first at the desired size that will not develop necrotic center and then
seed them to the limited-adhesion material in 3D environment.
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From the experiments performed in this work, we found that the higher the flow rate of
seeding, the better the seeding efficiency. On the other hand, it seems that 20 ml/min seeding
flow rate was not enough to seed the aggregates while it’s efficient for single cell suspension
seeding. The spheroids were accumulated in the central port and not evenly distributed into
pores; which resulted in one massive spheroid that has poor oxygen and nutrients transport
efficiency (specially at the center) and may have resulted in developing necrotic center.
In addition, single pass seeding at room temperature with cold medium (4°C) resulted in
better seeding efficiency for both seeding architectures and lower LDH activity. Hepatocytes
have high metabolic rates, and by seeding with solutions at 4°C, we lower their activity and
make them less sensitive to any oxygen deprivation.
Calculations based on hepatocyte oxygen uptake rates suggests that flow rate should be
higher than 14.4 ml/min to meet hepatocyte oxygen requirements (if inlet oxygen partial pressure
to bioreactor was considered to be 158 mmHg (O2 atmospheric partial pressure) and outlet
pressure was 35 mmHg (perivevous zone in liver). On the other hand, calculations based on
physiological shear stress at the sinusoid (5 to 20 dyne/cm2) and the volumetric flow rate in our
porous scaffold suggests that flow rate should not exceed 5.67 ml/min.
While a flow rate of 20 ml/min was adequate for seeding a cell suspension, it was too low to
efficiently seed spheroids into the scaffolds. The spheroids settled in the central port and did not
distribute into pores, resulting in excessive spheroid aggregation, diffusion limitations, and cell
death. Seeding flow rate of 20 ml/min and culturing at 15 ml/min may have resulted in
hepatocyte damage and death due to high shear stress forces.
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5.5

Conclusions and Future Work
•

Available data indicate that effective hepatocyte seeding and perfusion culture requires
higher flow rates that raise the risk of shear-induced cell damage. Alternate methods for
enhancing diffusional transport in these systems are needed.

•

Seeding with pre-formed spheroids has higher efficiency than seeding with cell
suspension with higher cell viability, too. On the other hand, hepatocytes performed their
metabolic functions at higher rates when seeded as single cell suspension compared to
seeding with pre-formed spheroids.

•

Poor performance and low viability of hepatocytes seeded as pre-formed spheroids
resulted from the spheroids settling down at the central port and forming a one-massive
aggregate where most of the cells don’t receiving the required oxygen and nutrients and
eventually die. Increasing the seeding flow rate beyond 20 ml/min was not a valid option,
as this flow rate will expose the hepatocytes to even higher shear forces and they will
definitely die from that.

•

Modifications to the perfusion system can be made to maintain the hepatic specific
functions in vitro by insuring the adequate delivery of oxygen and nutrients and removal
of the waste products; i.e. co-culture with MSCs to shield them from excessive shear
forces and in the same time initiate vasculogenesis in the spheroids by differentiating
MSCs to endothelial cells.
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CHAPTER SIX
THE EFFECTS OF CO-CULTURING HEPATOCYTES WITH BONE MARROW
MESENCHYMAL STEM CELLS

6.1

Introduction
The vascular network in the liver and the bile drainage system are crucial to both the

viability of hepatocyte cells and the detoxification of the blood. Hence, tissue engineered
systems should address the need of such networks. Incorporating microvascular endothelial cells
to the in vitro cultures will help in the vasculogenesis, angiogenesis and anastomosis with the
host vascular network. It will enhance hepatocytes viability and their specific functions, as this
will mimic the natural environment in the liver as well as protect them from any excessive shear
forces they might experience in the dynamic perfusion system. This approach is hindered by the
availability of such cell populations and the difficulties in isolating endothelial cells at high
yields, specifically sinusoidal endothelial cells (SECs). SECs lose their phenotype rapidly after
isolation and their survival depends on co-culturing with primary hepatocytes. There are limited
in vitro configurations that can accommodate such populations and they can’t be passaged and
hence they senesce rapidly [97-100].
Mesenchymal stem cells can provide an alternate cell source to substitute for endothelial
cells if either differentiated before co-culturing with hepatocytes [65, 101, 102], or differentiated
while co-culturing under flow conditions [64]. MSCs might also provide an alternate cell source
to substitute for primary hepatocytes [103-106] in hepatocyte transplantation because of their
multiple differentiation potential and nearly unlimited availability.
It has been shown that co-culturing hepatocytes with BM-MSCs enabled the restoration
of hepatocyte cell polarity due to the ECM secreted by MSCs (e.g. collagen Type-I) as well as
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providing a number of cues for hepatocyte growth and development [59]. Also, MSCs can be
differentiated into connective tissue cells; i.e. endothelial cells. Wang et al. [64] demonstrated
the ability of murine embryonic mesenchymal progenitor cell line, C3H/10T1/2 to differentiate
into cells that express mature endothelial cell–specific markers such as CD31 and von
Willebrand factor [64, 107].
The objective of this work was to optimize the spatial arrangement of hepatocyte (HCs)
and bone marrow mesenchymal stem cells (MSCs) to produce more effective cell-cell contact in
3D environment. This could be achieved by optimizing seeding architecture.
As part of this work, we also examined heterotypic cultures in perfusion system. The
premise was that MSCs can provide protection against shear forces by differentiating to vascular
phenotypes as well as secreting ECM components that may associate with and hence stabilize the
cell membranes of hepatocytes.

6.2

Experimental Work

6.2.1

Materials
CellTracker™ Calcein Red-Orange AM and CellTracker™ Green CMFDA dyes were

purchased from Life Technologies (Thermo fisher Scientific Inc.). All other chemicals and
solvents were of analytical reagent grade.

6.2.2

Bone Marrow Mesenchymal Stem Cells Isolation and Culture

The same hepatocytes donors rats were used to isolate bone marrow mesenchymal stem cells
following a protocol described by Karaoz et al. [108] and slightly modified by our group.
Briefly, femur and tibiae were excised then all muscles and connective tissues were detached.
The whole bones were then soaked and vortex mixed in ringer solution (without enzymes) for 30
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minutes to remove excess soft tissue. After that, the epiphyses were cut away by torsion-twisting
off using two Kelly clamps. The diaphyses cavities were then flushed with pre-warmed DMEM
(low glucose) supplemented with 10% FBS, 50 mg/L gentamicin and 2.5 mg/L Fungizone (same
medium was used for cells culture as well). This flushing was carried out using 18-gauge needle
inserted into the shafts to extrude the bone marrow. Marrow plug suspension was then dispersed
by pipetting, successively filtered through 70-µm mesh nylon filter into sterile 50 ml centrifuge
tube and then centrifuged 200 x g for 10 min. Supernatant containing thrombocytes and
erythrocytes was discarded, and the cell pellet was resuspended in sterile PBS and centrifuged
(repeated two times). At the final wash, the cell pellet was resuspended in culture medium and
cells from one rat were seeded onto four 10 cm culture dishes (7 ml per dish) and incubated at
37°C in a humidified atmosphere containing 5% CO2 for 3 days without changing medium. On
the third day, red blood cells and other non-adherent cells were removed and fresh medium was
added to allow further growth. The adherent cells grown to 70% confluency were defined as
passage zero (P0) cells.

6.2.3

Chitosan-Heparin Disc Scaffolds Fabrication and SEM Imaging
Porous disc scaffolds were prepared by freezing the same chitosan solution in 96-well

plate with stainless steel bottom (Fig. 36). Disc scaffolds designated for cell culture were
neutralized with 5% ammonia, washed with PBS, derivatized with Heparin, sterilized by soaking
in 80% ethanol for 48 hours and finally incubated with medium containing 10% FBS for 24 hrs
prior to cell seeding. Discs used for SEM imaging purposes were kept dehydrated and sputter
coated with gold for imaging; one of them was cut longitudinally to view the pores directions.
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Figure 36: Fabrication of chitosan disc scaffolds.

6.2.4

Cell Labeling with Fluorescent Dyes
For hepatocytes, the CellTracker™ Green CMFDA dye was used as manufacturer’s

recommended protocol. First, the dye powder was dissolved in 5 µl sterile DMSO to make 10
mM (molecular weight of dye is 464.8) then diluted in 2 ml culture medium (serum free) to make
25µM working solution. The solution was then warmed up to 37°C and used to resuspend the
hepatocytes. After that, the suspension was incubated for 30 minutes in 15 ml centrifuge tube in
ice (reduce hepatocyte metabolic rate). The cells were then centrifuged at 300 rpm for 5 min and
the dye working solution was replaced with fresh, pre-warmed medium. The hepatocytes were
now ready to be seeded into the scaffolds.
For MSCs, CellTracker™ Calcein Red-Orange AM dye was used following manufacturer
instructions. The dye molecular weight is 789.55; it’s dissolved in 6.3 µl DMSO to make 10 mM
stock dye solution then diluted in 2.53 ml culture medium (serum free) to make 25µM dye
working solution. The dye working solution was added to MSCs growing in a 100 mm dish and
incubated for 30 minutes and then was replaced with fresh, pre-warmed medium. The cells were
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incubated again for another 30 minutes at 37°C then trypsinized and resuspended in fresh, prewarmed culture medium to be seeded into the scaffolds.

6.2.5

Cell Seeding and Culture into Three Different Architectures
Three different seeding architectures were examined as illustrated in table 6. Seeding was

done with single cells suspensions of either hepatocytes only or hepatocyte with MSCs at 2:1
ratio as described by Gu et al. [109], and cultured on orbital shaker (~50 rpm) to enhance mass
transfer in the wells. Culture medium was the same as hepatocyte culture medium mentioned
above. Collagen gel sandwich configuration was used as control.
The seeding density was chosen based on the work done by Glicklis et al. [110]. They
used a seeding density of 5X 105 cells/scaffold/ml for scaffolds of 1.5 cm diameter and 1.0 cm
height. The disc scaffolds fabricated in our lab were 0.64 cm in diameter and 0.2 cm in height
for 96-well plate, and 1.14 cm in diameter and 0.1 cm in height for 48-well plate. The required
seeding density was 0.018 million cells per disc scaffold in the 96-well plate and 50,000 cells/
cm2 in the 48-well plate. Monolayer seeding density based on the unit area was also examined
(100,000 cells/cm2).

Table 6: Seeding architectures. Four different seeding architectures into the chitosan-heparin disc scaffolds.

6.2.6

AlamarBlue® Viability Test in the Chitosan-Heparin Disc Scaffolds

AlamarBlue® cell health indicator assay was performed as described by manufacturer.
Briefly, AlamarBlue® was added to the cultured cells at a dilution of 1:10. The cells were
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incubated with AlamarBlue® for three hours; where fluorescent was measured by collected
samples after one hour (T1) and after three hours (T2). The resazurin reduction rates were then
calculated for each condition.

6.2.7

Spheroids Sizes Measurement and Statistical Analysis for Spheroids Formed in Disc

Scaffolds
Phase contrast images using a digital camera were captured for each condition on days 7 and
17 of culture. At least five images per condition were taken, and the diameters for the spheroids
were measured using ImageJ® software. The mean diameters and standard deviations were
calculated and then plotted using SigmaPlot® software. One-way ANOVA statistical analysis
was performed to evaluate the spheroid reduction in size between the two measurements per each
condition. A p-value < 0.05was considered to be significant.

6.2.8

Monotypic and Heterotypic Perfusion Cultures in Chitosan-Heparin Scaffolds
Porous scaffolds with a closed ended, annular structure and radial pore architecture

(described previously in Fig. 12: surface frozen scaffolds) were used in this experiment. The
chitosan scaffolds were modified with heparin, sterilized with 80% ethanol, washed with sterile
PBS and perfused with 10% FBS culture medium for 24 hours prior to seeding. The same
bioreactor described previously was used (in Fig. 13: surface frozen scaffolds). Cells were
seeded as single cell suspensions with cold medium repeated one way (non circulating) passes at
20 ml/min and cell concentration of 35 million/ml. One scaffold was seeded with hepatocytes
only (monotypic culture) with 100 million cells suspended in 35 ml cold medium. One scaffold
was seeded with mixed cells suspension of MSCs and hepatocytes (heterotypic culture) (70
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million hepatocytes plus 27.925 million cells MSCs at 2:1 ration). Seeding efficiency was
estimated by counting the cells that were not seeded into the scaffolds after the seeding period).
The flow rate used subsequently was 15 ml/min all along the whole culture period. Media
samples were collected daily for metabolic function assays (albumin synthesis and urea
secretion) and LDH activity assay. Scaffolds were fixed in 10% formaldehyde and processed for
histology (H&E staining).

6.2.9

Hepatocyte Metabolic Functions Assays (Albumin Synthesis and Urea Secretion)

Metabolic performance of cultured hepatocytes was evaluated by measuring: (1) the rate of
albumin synthesis via Enzyme-linked immunosorbent assay (ELISA) using antibody specific to
rat albumin and (2) the rate of urea secretion using diacetyl- monoxime colorimetric method
described by Rozet et al. [84] and. Media samples were collected daily for metabolic functions
analysis (albumin and urea secretion). Measurements were performed in triplicate (n =3). Data
were plotted as means with error bars representing standard deviation.

6.3

Results

6.3.1

Pores Dimensions and Architecture as Shown by Scanning Electron Microscopy

(SEM)
The goal was to produce spheroids that were limited in size to < 100 µm by controlling
pores sizes. The pore size was controlled by the amount of chitosan solution added to each well
as well as the freezing time. For 96-well plate, the amount of chitosan solution added to each
well was 0.05 ml. For 48-well plate, 0.1 ml of chitosan solution was added to each well. The
freezing time was 15 min in Isopropanol/dry ice bath.
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The pores at the bottom of the scaffolds were very small (Fig. 37A) (almost sealed) and
the pores opening at the top were of sizes about 100 µm (Fig. 37B). The pores were
longitudinally directed and were tapered towards the bottom of the scaffolds (Fig. 37C) so they
will hold the spheroids in place and in the same time prevent them from fusing together.
A

B

C

Top side

Bottom side

Figure 37: SEM images of chitosan disc scaffolds. (A) Bottom view, (B) top view, and (C) longitudinal
cross section.

6.3.2

Cell Morphology in the Disc Scaffolds
MSCs were seeded one day prior to hepatocyte formed spheroids in the chitosan-heparin

surfaces (Fig. 38A&B). Hepatoctyes in collagen gel sandwich formed one layer of cells with bile
canaliculi network formed as evidence of the dye CellTracker™ Green CMFDA secreted to the
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bile (Fig. 38C&D). The H&E histology images showed that hepatocyte/MSCs spheroids (Fig.
38E) were smaller in size with tightly-fused cells, while hepatocytes only spheroids (Fig.40F)
were bigger in size with less fused cells.

Figure 38: Cell morphology in the disc scaffold system. Phase contrast images (A&C), digital color
fluorescent images (B&D) and H&E histology images (E&F) of hepatocyte/BM-MSC co-cultures in disc
scaffolds cultures. (A&B) MSCs only (day 2 of culture), (C&D) hepatocytes in collagen gel sandwich,
(E) hepatocyte/MSCs co-culture, and (F) hepatocytes only after two weeks in culture. Hepatocytes were
labeled with CellTracker™ Green CMFDA dye and MSCs were labeled with CellTracker™ Calcein RedOrange AM dye. Scale bar 100 µm.
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The cells formed compact spheroids with well-defined smooth surfaces in all the mixed
co-cultures (Fig. 39A, C, and E). Hepatocytes formed loose spheroids with rough surfaces
aggregates in the mono-cultures (Fig. 39G). For condition #1; where MSCs were seeded one day
prior to seeding hepatocytes, the MSCs formed spheroids in the center and hepatocytes
surrounded them at the peripheries as evidence of fluorescent images (Fig. 39B). For conditions
#2 (mixed suspensions of MSCs and hepatocytes) and condition #3 (hepatocytes seeded one day
prior to MSCs), the spheroids looked like they were mixed populations of both MSCs and
hepatocytes without defined arrangement (Fig. 39D&F). It was noticed from the fluorescent
images that the CellTracker™ Green CMFDA dye was not uniformly distributed in the
hepatocyte cytosol; which indicates that the bile canaliculi network may have been formed inside
the spheroids (Fig. 39B, D, F and H). When fluorescent intensity quantified for each condition
(Fig. 40), we noticed that hepatocytes and MSCs had the highest fluorescent activities in
condition #2 where they were mixed together as cell suspensions which indicates that more cells
were viable at this seeding architecture compared to the other seeding conditions. In addition, as
CMFDA dye was expressed more in condition#2, it indicates that the hepatocytes have stronger
polarizations expressed as the MSCs were mixed with hepatocytes at the same time before they
form the aggregates which may have contributed to better polarization during the aggregation
process. We also examined the efficiency of hepatocyte membrane polarization by measuring the
fluorescent intensity when labeling with anti-Connexin 32 (gap junction protein) (Fig.41A) and
anti-ZO-1 (tight junction protein) (Fig. 41B). Condition #2 (mixed suspensions of hepatocytes
and MSCs) had the strongest fluorescent intensity for anti-Connexin 32. When the seeded discs
were cultured in an un-agitated condition, there were no significant difference between the gap
and tight junctions’ expressions. All co-culture conditions expressed higher intensities compared
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to the mono-cultures (hepatocytes only) which indicate better membrane polarization in the coculture systems.

Figure 39: Phase contrast images (A, C, E and G) and digital color fluorescent images (B, D, F and H) of
hepatocyte/BM-MSC co-cultures in disc scaffolds cultures after one week of culture. Condition #1: MSCs
then hepatocytes (A&B), condition #2: mixed suspensions of MSCs and hepatocytes (C&D, condition #3:
hepatocytes then MSCs (E&F), and condition #4: hepatocytes only (G&H). Hepatocytes were labeled
with CellTracker™ Green CMFDA dye and MSCs were labeled with CellTracker™ Calcein Red-Orange
AM dye. Scale bar 100 µm.
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Figure 40: Fluorescent intensities quantification for all seeding architectures for hepatocytes labeled with
CellTracker™ Green CMFDA dye and MSCs labeled with CellTracker™ Calcein Red-Orange AM dye
(on day 7 of culture). Measurements were performed for different number of spheroids (n =5 to 20). Data
plotted as means with error bars representing standard deviation (SD).

82

Figure 41: Mean grey value Intensities for (A) anti-Connexin 32, and (B) anti-ZO-1. Measurements were
performed for different number of spheroids (n =3 to 16). Data plotted as means with error bars
representing standard error of means (SEM).There is not a statistically significant difference between
Shaking and Non-Shaking groups (P < 0.05 ).
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6.3.3

Spheroids’ Sizes at 50,000 cells/ cm2 and 100,000 cells/ cm2 Seeding Densities

The spheroids formed in the co-culture conditions were smaller in size compared to those in
mono-cultures. For seeding density of 50,000 cells/ cm2, the spheroids average diameters were
about 227± 13, 218± 30, 350± 41, and 341± 35µm on day 7 of culture for all four conditions
respectively, and 211± 25, 315± 49, 437±112, and 314± 18 µm on day 17 with no significant
difference between the four different seeding architectures (Fig. 42A). The spheroids were larger
in size in the100,000 cells/ cm2

compared to the lower seeding density for all seeding

conditions, with no significant difference between the groups (Fig. 42B).
For seeding density of 50,000 cells/cm2, the conditions #1 and #4 exhibited reduction in
spheroids sizes while the other two conditions had increased spheroid sizes (Fig. 42A). On the
other hand, for seeding density of 100,000 cells/cm2, there were decrease in spheroids sizes from
day 7 to day 17 of culture for all conditions, except when MSCs were seeded after one day of
hepatocytes there were increase in size (Fig. 42B). We noticed for both seeding densities,
spheroids actually got larger for condition # 3 where MSCs were seeded one day after
hepatocytes were seeded (Fig. 42A & B). The increase in size though was not large enough to be
due to spheroids fusion (about 50 µm increase). This was more consistent with a reasonable
increase in cell number due to MSCs growth, given the fact that MSCs were present at the outer
surface of the spheroids. In addition, MSCs are known to be not as shear stress sensitive as the
hepatocytes, so they were able to prolifirate and grow with damages. On the other hand, when
hepatocytes were present at the surface of the spheroids (as in conditions #1 and #4), they were
more exposed to shear forces and hence shear damage which have resulted intheir death and deattachements from the spheroids and consequently, reduction of spferoids sizes.

84

Figure 42: Spheroids mean diameters for (A) Seeding density of 50,000 cells/ cm2, and (B) Seeding
density of 100,000 cells/ cm2. Measurements were performed for different number of spheroids (n =5 to
20). Data plotted as means with error bars representing standard error of mean (SEM).

85
6.3.4

AlamarBlue® Cell Haelth Indicator Assay

AlamarBlue® activity for seeding density 100,000 cells/ cm2 was lower than the activity of
50,000 cells/ cm2 seeding density on day 7 (Fig. 43A) and day 17 (Fig.43B). This observation
was in agreement with the hypothesis that more cells were competing for nutrients and supplies,
and hence, resulted in lower number of viable cells (as lower AlamarBlue activity indicates less
number of viable cells available).
We can notice here that the activity decreases in general from day 7 to day 17 for all
conditions (Fig. 44A&B) as hepatocytes were being exposed to damaging shear stresses and
hence they lost their viability.

6.3.5

Hepatocyte Metabolic Functions and Viability

For seeding architecture condition # 1 (MSCs seeded one day prior to hepatocyte), the
albumin rates were close to those for collagen gel sandwich controls in the first five days of
culture and dropped afterwards, while urea secretion rates were fluctuating between either higher
rates or similar rates to the collagen gel sandwich configuration (Fig. 44A&B). As MSCs formed
spheroids first, then hepatocytes surrounded them at the peripheries, this configuration may have
exposed more hepatocytes to the shear forces and caused the rapid decline in their functions
compared to the preserved ones in the other two configurations.
For seeding architectures condition #2 (mixed suspensions of MSCs and hepatocytes) and
condition #3 (hepatocytes then MSCs), hepatocytes synthesized albumin at rates similar to those
in the control collagen gel sandwich configuration in the first week of culture and then it
declined in the second week of culture (Fig.44C&E). They secreted urea at rates substantially
higher than collagen gel sandwich cultured hepatocytes (Fig. 44D&F). The enhanced hepatic
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functions were hypothesized to be due to substrates secreted by MSCs and utilized by
hepatocytes that made them more tolerant to shear stresses.
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Figure 43: AlamarBlue® reduction rate for both seeding densities 50, 000 cells/ cm2 and 100,000
cells/cm2 on: (A) Day 7 and (B) Day 17 of culture time. Measurements were performed in triplicate (n
=3). Data plotted as means with error bars representing standard error of mean (SEM). (P< 0.05)
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Hepatocytes cultured without MSCs in the three dimensional environment synthesized
albumin at lower rates than collagen gel sandwich configuration (Fig. 44G), while urea secretion
was elevated (Fig. 44H). This suggests that monotypic cultures lack necessary signals that MSCs
were able to provide in the heterotypic cultures.
After two weeks of culture (~17 days), in all heterotypic conditions, neither albumin nor urea
was detected; this suggests that hepatocytes de-differentiated and lost their metabolic functions.
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Figure 44: Metabolic functions of hepatocytes/BM-MSCs cultured disc scaffolds. Albumin secretion
rates (A, C, E and G) and urea secretion (B, D, F and H) of hepatocyte/BM-MSC co-cultures in disc
scaffolds cultures for the four seeding architectures. (A&B) condition #1: MSCs then hepatocytes, (C&D)
condition #2: Mixed suspensions of MSCs and hepatocytes, (E&F) condition #3: Hepatocytes then MSCs,
and (G&H) condition #4: Hepatocytes only cultures. Measurements were performed in triplicate (n =3).
Data plotted as means with error bars representing standard deviation.

6.3.6

Mathematical Model for Urea Production Rate
Since we didn’t see continuous decline in the urea production rates, we assume that the

aggregates were divided into two zones (outer and inner) that produce urea at two different rates
based on their proximity to the nutrients and oxygen source (media). The fluctuation was mostly
noted in condition #1 and condition #4; where hepatocytes were arranged at the outer surfaces of
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the aggregates. This phenomena was not observed in conditions #2 (mixed suspensions of
hepatocytes and MSCs) and condition #3 (MSCs seeded one day after hepatocytes aggregated
formed). The outer layer of cells in a given aggregate (ZoneOUT) was exposed to the agitating
medium and hence exposed to high mass transport in addition to high shear forces. The cells in
this zone were arranged as one-cell thick layer. The rest of cells were at the inner region of the
aggregate which was named ZoneIN. The aggregates were arranged as hemispheres as they
mostly set on top of the material. There were two scenarios suggested (Fig. 45; scenario #1 when
the outer layer cells were alive and functioning, and scenario #2 where the outer layer cells were
dead, non-functioning but still attached to the aggregate. After one day of scenario #2, the dead
cells will de-attach from the aggregate hence the diameter was reduced and we go back to
scenario

#1

and

so

forth.

Figure 45: Schematic diagrams represent two scenarios: high and low metabolic functions and the two
zones in a given aggregate.
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To quantify the urea production rate for each zone, we assume a proportional relationship
between production rate and oxygen concentration at that zone [111]. In order to find the oxygen
concentration profile for each zone, mass transfer continuity equation in spherical coordinates
was applied for steady-state system and constant ρ and DAB [112]. The diameters of the
aggregates were extrapolated from the two measurements made on day 7 and day 17; where a
linear relationship was generated to calculate the diameters for every day of the whole culture
period.

0 = &'( )

* -

+ , -+

-./
-+

$0 − 1 ………………… (1)

Where;
DAB is the oxygen diffusion coefficient in hepatocytes (3.4 X 10-10 m2/s).
K is the oxygen consumption rate (OCR) in hepatocyte spheroids with diameter less than 300 µm
(1.5 X 10-5 µg/mm3/s); which was assumed to be a zero order reaction as OCR reaches plateau
value independent from the local oxygen partial pressure at the range of interest (considered as
high oxygen concentration) [91].
Solutions for the equation were obtained for the two different scenarios:
Scenario #1: outer layer of cells alive, so both diffusion and reaction terms were considered. The
boundary conditions are:
1) Radial symmetry around the center
@ =0 →

-.456
-+

=0

2) At the surface of the spheroid it’s maximal (bulk) concentration
@ =

789

→ :;<= = :>?@A
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Where; :>?@A is the bulk oxygen concentration,
spheroid radius. For ZoneOUT the limits are

789

is the radial coordinate and

− 25 ≤

≤

789

789

is the

.

The oxygen concentration profile at ZoneOUT for scenario #1 is given by solving Eq. 1 above for
the boundary conditions given:
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H………………… (2)

The concentration of oxygen in ZoneIN was averaged (Cav.) over a differential volume using the
following formula:
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………………… (3)

The :IJ. at ZoneIN can be calculated by the final equation:
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+
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Where,
=

789

− 25 .

Scenario #2: outer layer of cells was compromised due to shear forces damage, so no reaction
term was considered, only diffusion and using Eq. (1) above with K =0.
The boundary conditions are:
1) At the surface of the spheroid it is maximal (bulk) concentration
@ =

789

→ :;<= = :>?@A

2) Flux at interface is equal from both zones
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The oxygen concentration profile at ZoneOUT for scenario #2 was obtained by solving Eq.1 above
given by:
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The :IJ. at ZoneIN was calculated using Eq. (2) and Eq. (3) and given by the final equation:

:IJ. = :>?@A −
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Where,
=
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− 50 .

Finally, the rates of urea production (b;<= and bcd

e/g ) were calculated using a linear

equation derived from the urea production rates in collagen dish sandwich at known oxygen
concentrations ( e/g

by the following equation:
b;<=/cd = 2.98 ∗ :;<=/cd ………………… (7)

The calculated urea rates were then multiplied by the total number of live cells per zone. The
total urea production rate was the summation of the urea production rate per zone.

Results of Mathematical Model
Figure 46A illustrates the total urea production rate for condition #1 (MSCs seeded one
day prior to seeding hepatocytes) for the first week of culture as predicted by the model versus
the actual measured values. In the co-culture system, we have seen higher urea secretion rates
than the predicted values based on mono-culture system. The model assumes that a whole layer
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of cells at the outer surface of an aggregate was damaged by shear force and removed. While in
the actual cultures that might not be exactly the case; some of the cells at the outer layer were
damaged and removed not the whole layer of cells. Also, the model predicts the urea secretion
values based on a base line of the secretion in the collagen gel mono-cultures. The elevated
levels of urea secretion may have been caused by a combination of the 3D culture architecture
and substrates or cues secreted by MSCs and used by hepatocytes; e.g., MSC-derived matrix,
growth factors, and ammonia. These results are in agreement with previous reports; Isoda et al.
[113] found that soluble factors secreted from BM-MSCs had the effect of maintaining liverspecific functions and significantly increase urea secretion and albumin synthesis. Similarly,
when culturing porcine hepatocytes with BM-MSCs at a ratio of 2:1, immunocytochemical
staining studies by Gu et al. [109] revealed that polarity-restored, organotypic islands of
hepatocytes were surrounded with a dense ECM network that was secreted by MSCs. These
studies further confirmed the roles of fibronectin, laminin, and collagens assembly within close
link between cellular architecture and hepatocyte functions. If we assume a base line of urea
secretion as the value in a co-culture system, eq. (7) will change to:
b;<=/cd = 6.4 ∗ :;<=/cd ………………… (8)
And then the predicted values were closer to the measured values (Fig. 46B). But we still see
drop of the production on days 5 and 7 (almost zero); this phenomena may have been caused by
the release of cellular bi-products from dead cells that were negatively affecting metabolic
functions of surviving hepatocytes. Another hypothesis for this drop was that MSCs were
proliferating and their nutrients and oxygen demands were increased which caused depletion in
their availability for hepatocytes use.
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In addition, we have also seen higher magnitude of fluctuation in the conditions where
hepatocytes were most likely to be at the outer layers of the aggregates (condition #1 and
condition # 4). In the other two seeding arrangements (condition #2 and 3), the hepatocytes were
less exposed to shear forces and most likely protected by the MSCs. In condition #3, MSCs were
actually seeded one day after seeding the hepatocytes. This seeding arrangement allowed the
hepatocytes aggregates to form first, and then MSCs attached to the outer layer which may have
provided physical barrier against shear forces. In seeding condition #2, where mixed cell
suspensions of hepatocytes and MSCs were seeded at the same day, in which MSCs may have
secreted cues that made hepatocyte membranes more shear resistant. Moreover, MSCs
contributed to providing some physical barrier by segregating themselves to the outer layer of the
aggregates.
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Figure 46: Total urea production rate for condition #1 (predicted vs. measured) when (A) and collagen
gel values used as base line for predicted values (B) co-culture values used as base line for predicted
values

6.3.7

Metabolic Performance of Heterotypic Cultures in the Perfusion System
The seeding efficiency in both monotypic seeded scaffold and heterotypic seeded

scaffold were about 66%. Under dynamic conditions, seeding flow rate of 20 ml/min at 4°C and
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culture flow rate of 15 ml/min, hepatocyte-MSC (heterotypic culture) seeded scaffold secreted
urea at higher levels than scaffold seeded with hepatocytes only (monotypic culture) (Fig. 47A).
Very low albumin levels were detected in the heterotypic seeded scaffold but at very depressed
rates compared to the collagen gel sandwich static control (Fig. 47B), no albumin levels detected
for the monotypic scaffold. Cells in both scaffolds expressed high levels of LDH activity (Fig.
47C). This suggests that hepatocytes were not functioning maybe due to high shear forces in the
system.
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6.3.8

Cell Morphology and Neo-Tissue Formation in Perfused Scaffolds Heterotypic

Cultures
MSCs formed layers of cells blocking inner pores (Fig. 48A) and outer pores (Fig. 48B),
which may have affected the flow dynamics inside the scaffold (low nutrients supply and high
shear forces). The cells look unhealthy and heavily damaged and deteriorated (Fig. 48C), and
most of hepatocytes nuclei did not stain purple which indicate they were dead at the time of
fixation.
It was noticed that new structures has been formed in the heterotypic-dynamic perfused
scaffolds. Fat droplets appeared in some new tissues (Fig. 48D), formation of blood vessels like
structures and hollow spheroids were noticed in the heterotypic seeded scaffold and not noticed
in the monotypic culture (Fig. 48E & F). Some positive staining for CD31 marker was observed
in the neo-tissue (Fig. 48G). Platelet endothelial cell adhesion molecule (PECAM or CD31) is
found on the surface of endothelial cells and function as intercellular junction protein [107]
(positive control Fig. 48H).
When the H&E histology sections were exposed to blue color light, hepatocytes appeared
to fluoresce a green color with dark circles within the cytoplasm indicating the nucleolus (Fig.
49A). MSCs didn’t fluoresce any colors, which gave us better idea how the two types of cells rearranged themselves (when the fluorescent images compared side by side with the color images
for the same sections) (Fig. 49B). We can conclude from both types of images that MSCs form
mono layers around hepatocytes spheroids, with some cells embedded inside the spheroids
(yellow arrows in Fig. 48B). It was also noticed that MSCs seem to segregate to the surfaces
(Fig. 48A-B and E-F). The hollow structures formed appeared to be lined with single cell layer
of MSC with hepatocytes aggregates built up around the holes (Fig. 49C-H).
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Figure 48: H&E histology images of cross sectional areas for MSCs-hepatocytes perfused scaffolds
illustrating: (A) layers of cells blocking central port pores, (B) layers of cells covering the outer surface of
the whole scaffold, (C) cell debris, (D) Fat droplets, (E & F) Blood vessels-like structures (arrows), and
(G&H) Immunohistochemistry images for CD31 (H is control).
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Figure 49: H&E histology images of cross sectional areas for MSCs-hepatocytes perfused scaffolds (A,
C, E and G) under blue-color light, and (B, D, F and H) under normal-white light.
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The hollow structures diameters range from 15.27 to 57.42 µm, which could be any type
of blood vessel (from a vein to a capillary).
Masson Trichrome histology images revealed that some collagen was deposited in these
cultures, but at very small quantities (Fig. 50).

Figure 50: Masson Trichrome staining images of cross sectional areas for MSCs-hepatocytes perfused
scaffolds. Arrows are pointing to faint blue-colored collagen.

6.4

Discussion
Culturing hepatocytes with MSCs on weakly-adhesive surfaces resulted in forming small-

very compact spheroids. While culturing them without MSCs results in larger and looser
aggregates. These very compact spheroids may have prevented adequate mass transfer and hence
resulted in hepatocyte death in the long term culture.
Hepatocyte-MSC 3D disc scaffold culture results show enhanced metabolic functions in the
first week of culture (short term cultures). This suggests that the elevated levels of urea secretion
may have been caused by a combination of the 3D culture architecture and substrates or cues
secreted by MSCs and used by hepatocytes; e.g., MSC-derived matrix, growth factors, and
ammonia. In effect, MSCs and their heterotypic signals may have partially protected hepatocytes
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from hypoxia in a three dimensional environment with limited circulation. These results were in
agreement with previous reports; Isoda et al. [113] found that soluble factors secreted from BMMSCs had the effect of maintaining liver-specific functions and significantly increase urea
secretion and albumin synthesis. Similarly, when culturing porcine hepatocytes with BM-MSCs
at a ratio of 2:1, immunocytochemical staining studies by Gu et al. [109] revealed that polarityrestored, organotypic islands of hepatocytes were surrounded with a dense ECM network that
was secreted by MSCs. These studies further confirmed the roles of fibronectin, laminin, and
collagens assembly within close link between cellular architecture and hepatocyte functions.
The heterotypic cultures in 3D disc scaffolds didn’t perform well in terms of albumin
synthesis in the long term culture. Prior studies suggest that albumin synthesis by hepatocyte
spheroids was not affected by the oxygen tension, it was rather influenced by other factors such
as the greater extent of heterotypic cellular interactions at the lower co-culture ratios and the
number of viable hepatocytes in the formed spheroids [110]. It has also been shown that when
hepatocytes were exposed to shear forces higher than 5 dynes/cm2 albumin synthesis rate was
significantly decreased. Therefore, increasing medium flow rate will provide higher supplies of
nutrients and oxygen to the cells, but it also damages them [3, 114]. Given our orbital shaking
system for the disc scaffolds, we speculate that there was a cyclic effect of shear forces due to
shaking. The wall shear stress (τw) in the orbital shaking system can be estimated using Stokes’
approximation [115]. For a constant rotational speed (Ω =50 rpm) and an orbital radius of
agitation (Rg =3.175 cm), the wall shear stress was estimated to be constant over the plate bottom
surface and has a value of ~0.25 dyne/cm2. This value was calculated for an empty well, while
the wells in the experiments conducted here were filled with high porous chitosan scaffolds
seeded with spheroids and culture medium. In addition, Salek et al. [115] results showed that τw
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varies with different volume fills of the wells, the higher the volume the higher the shear forces
will be. Hence, the fluid flow was turbulent in the wells as velocity vectors in the perpendicular
planes varies along the bottom surface of the well, which would have increased the wall shear
stress magnitude in the radial direction for values much higher than 0.25 dyne/cm2 (Fig. 51).
Tilles et al. [116] results showed that hepatocytes functions noticeably decreased when the flow
conditions resulted in wall shear stresses higher than 0.33 dyne/cm2. We offer this scenario to
explain the fluctuation in urea rates we observed in this set of experiments: the outer layers of
hepatocytes were exposed to the moving medium and hence express high rates of urea and
albumin. Due to the shear forces they were exposed to, these layers were damaged and they no
longer able to produce urea and albumin. The next day, the layers of dead cells were removed
exposing new-fresh layers of hepatocytes that secrets urea and synthesizes albumin.

Figure 51: Wall shear stress magnitudes on the bottom surface of rotating well at 100 rpm filled with 2
ml medium. The magnitude of reference vector is in Pa (1 Pa =10 dyne/cm2). [116]
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In the heterotypic perfusion system, MSCs blocked the pores which may have caused
poor circulation in some pores and elevated shear forces in others. This may have contributed to
hepatocyte death and overall poor metabolic functions. In addition, seeding MSC at the same
time of seeding hepatocytes (mixed cell suspensions of MSCs and hepatocytes) may have
interfered with the formation of cell-cell junctions between hepatocytes themselves and hence
didn’t allow them to form the required junction for their survival.
It was noticed that new structures were formed in the heterotypic-dynamic perfused
scaffolds. Some blood-vessel like structures (suggests vasculogenesis) and fat droplets formation
inside cells (suggests adipogenesis and lipocytes) were noted. This was due to the capability of
MSCs to differentiate into other phenotypes of supporting cells that will be beneficial for hepatic
neo-tissue formation in the field of bioartificial liver, i.e. endothelial cells or adipocytes.

6.5

Conclusions and Future Work
•

Hepatocyte-MSC 3D disc scaffold culture results suggest that elevated levels of urea
secretion may have been caused by a combination of the 3D culture architecture and
substrates or cues secreted by MSCs and used by hepatocytes; e.g., MSC-derived matrix,
growth factors, and ammonia. In effect, MSCs and their heterotypic signals may have
partially protected hepatocytes from hypoxia in a three dimensional environment with
limited circulation.

•

In heterotypic perfusion system, MSCs blocked the pores which may have caused poor
circulation in some pores and elevated shear forces in other poor. This may have
contributed to hepatocyte death and overall poor metabolic functions.
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•

Co-culturing with MSC is a potentially useful approach for hepatic neo-tissue formation
in the field of bioartificial liver.

•

Further studies are required to investigate enhancement of intra-aggregate diffusion by
using ECM-based microparticles to assemble mixed spheroids of hepatocytes and
vascular-differentiated mesenchymal stem cells.

•

Shear protection is required in these scaffold based microstructures. One possible method
is to encapsulate the cells with ECM material; e.g., shrink wrapping method based on
established soft lithography techniques describe by Palchesko et al. [117]. Or the
microencapsulation technology used at Dr. Matthew’s lab; a technique that is based on
the complex coacervation principle [118]. The use of chemical additives to protect cells
from fluid-mechanical damage is another possible solution. These additives are believed
to have two different protection mechanisms that act upon on the cell. The first
mechanism is of biological effect; the additive changes the cell itself to make it more
shear resistant by its physical incorporation into the plasma cell membrane. The other
mechanism is a physical protection; which means that the factors that are affecting the
level/frequency of transmitted shear forces to the cell in a given culturing system have
changed so that less cell damage is observed while the resistance of the cell to shear
remains unchanged. This can be achieved by changing the viscosity of the fluid the cells
are exposed to [119].
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CHAPTER SEVEN
THE EFFECTS OF ENCAPSULATING HEPATOCYTES WITH OR WITHOUT BONE
MARROW MESENCHYMAL STEM CELLS (BM-MSCS) WITHIN CHITOSAN-GAG
FIBERS ON HEPATOCYTE VIABILITY
7.1

Introduction
As noted in the previous chapters, hepatocytes lose their functions and de-differentiate

upon excision from their natural environment and cultivated in biomaterial matrices. Further, it
was concluded from the studies on the chitosan-heparin scaffolds that the shear forces have great
effects in hepatocytes viability and cause subsequent death upon perfusion in the dynamic
system. Hence, we sought other alternatives to shield the cells from these forces.
One promising approach is the encapsulation system. Microencapsulation has shown to
produce high density cultures when cells are encapsulated in ionic complexes between cationic
chitosan and anionic GAG. This encapsulation method can protect from shear damage in flow or
stirred cultures. Anchorage-dependent cells like hepatocytes can be provided with suitable
surfaces by co-encapsulating microcarriers or other ECM attachment materials. In addition,
microencapsulation will provide convenient method of cell handling and reduce cell damage that
can be caused by pipetting. This method can also allow microcapsules to retain and concentrate
secreted cellular products if the appropriate membrane permeability is achieved.

Finally,

microencapsulation methods are examined as means of providing the required barrier between
exogenous cells and the host immune system [118]. Microencapsulation can be in the form of
microcapsules or fibers. In this work, fibers were being investigated as possible approach for
hepatocytes encapsulation. When primary rat hepatocytes were encapsulated in HA-collagen
capsules and perfused with medium in a perfusion bioreactor system in previous work at Dr.
Matthew’s lab, they were able to maintain their metabolic functionalities for one week [120].
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The Objective of this work was to optimize fiber conditions for hepatocytes culture by
evaluating cell morphology and organization as well as metabolic function (albumin and urea
secretion). The GAGs investigated in this work were: Chondroitin Sulfate A (CSA), Hyaluronic
Acid (HA) and Heparin (HEP). HA-CHI formula has been shown to produce the thickest walls
without swelling of the capsules and on the other hand, CSA-CHI has a high attachmentenhancing effect were hepatocytes exhibited extensive aggregation [118, 121, 122].

7.2

Experimental Work

7.2.1

Materials
High molecular weight (HMW) chitosan from crab shells (molecular weight about 600

KDa with 75 - 85% Deacetylated chitin), Hyaluronic acid (HA) sodium salt from Streptococcus
equi (molecular weight

about 15,000– 30,000 Da), Heparin sodium porcine mucosa,

Chondroitin sulfate A (CSA) sodium salt from bovine trachea (molecular weight about 50–100
kDa, polygalacturonic Acid (PGA) sodium salt and carboxymethylcellulose (CMC) sodium salt
(medium viscosity with molecular weight about 250 kDa) were all purchased from SigmaAldrich (St. Louis, MO). Type I rat-tail collagen (2 mg/ml) prepared in house as described
elsewhere in this document was used. All other chemicals and solvents were of analytical reagent
grade.
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7.2.2

GAG-Chitosan Polyelectrolyte Complexes Formation into Fibers

Different compositions of GAGs with double strength collagen (2 mg/ml) were tested to
evaluate the wall thickness of the membranes formed using phase contrast microscopy and
evaluate their physical appearance in terms of stretching, snapping, rupturing and the ease of
handling.
The formulations of polyanionic solutions examined for fibers formation were as follows:
1) 8%CSA, 3%CMC, double strength collagen, 0% heparin.
2) 8%CSA, 3%CMC, double strength collagen, 0.5% heparin.
3) 8%CSA, 3%CMC, double strength collagen, 1% heparin.
4) 2%HA, double strength collagen, 0% heparin.
5) 2%HA, double strength collagen, 0.5% heparin.
6) 2%HA, double strength collagen, 1% heparin.
7) Mixture of 8%CSA and 2%HA with double strength collagen, 0% heparin.
8) Mixture of 8%CSA and 2%HA with double strength collagen, 0.5% heparin.
9) Mixture of 8%CSA and 2%HA with double strength collagen, 1% heparin.

All polyanionic solutions were made by dissolving each GAG separately in Sorbitol-HEPES
buffer contains: 0.4 g/L KCl, 0.5 g/L NaCl, 3.0 g/L HEPES.Na, and 36 g/L sorbitol in de-ionized
(DI) water with pH adjusted to ~7.4 [121]. The fibers were formed following the
microencapsulation protocol described by V. Lin and H. Matthew 2002 with double strength
collagen (2 mg/ml) interior [121]. The fibers were formed by extruding the GAG-collagen
solution through a 24G catheter using a syringe pump at flow rate of 0.34 ml/min. The fibers
were extruded into a beaker containing chitosan-sorbitol solution (final concentrations were 0.6
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wt% chitosan and 5.6 wt% sorbitol).The chitosan-sorbitol solution was made by mixing two
solutions prepared separately: (1) chitosan solution that was made by dissolving 3g of high
molecular weight chitosan in 250 ml DI water with 0.6ml acetic acid added after 24 hrs, and (2)
sorbitol solution made by dissolving 28.4g sorbitol in 250 ml DI water. After fibers were
extruded, they were allowed to set in the chitosan-sorbitol excess bath for two minutes, the fibers
were then washed with 0.9 wt% NaCl, then poured into beaker containing PGA (0.1 wt%) in
Sorbitol-HEPES buffer used for surface stabilization of the fibers.
For wall thickness evaluation study, the fibers were crushed under cover slips and phase
contrast images were collected.

7.2.3

Culturing Hepatocytes in Chitosan-GAG-Collagen Fibers
Based on the results from previous experiment, the formula of 2 % HA + 1 % heparin +

double strength collagen (2 mg/ml) composition was chosen to carry on cell culture experiments.
Hepatocytes only and MSCs with hepatocytes were encapsulated in the fibers as previously
described. 0.2 ml hepatocyte volume (~8 million) and 0.2 ml of GAGs + collagen solution were
extruded through a 24G catheter using a syringe pump at flow rate of 0.1 ml/min and the fibers
were pulled manually into chitosan-sorbitol excess bath and cut with a surgical blade into 1 cm
fiber long (Fig. 52A); into which each segment has about 1 million hepatocytes. The fibers were
then poured into beaker to be washed with 0.9 wt% NaCl for three times with shaking, poured
into another beaker filled with 0.1 wt% PGA and shook once and again rinsed with 0.9 wt%
NaCl. Finally, the fibers with cells were transferred to the culture wells in 6-well plate with 1 ml
of medium added to each well (without FBS) (Fig. 52B). For heterotypic cultures, 4 million
hepatocytes were mixed with 8 million MSCs (1:2 ratio) and the fibers were cut into pieces of 1
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cm length that contain about 1 million hepatocytes. Media samples were collected daily for urea
and albumin analysis and digital images were captured.
A

B

Figure 52: Hepatocytes encapsulated in fibers. (A) one-cm long fibers in chitosan-sorbitol bath. (B) Each
fiber was poured into a well of 6-well plate tissue culture plate with 1 ml hepatocytes medium.

7.2.4

Cell Distribution in a Bundle of Chitosan-Hyaluronic acid- Heparin- Double

Strength Collagen Fibers
Twenty million fixed hepatocytes (1:1 volume ratio of cell volume to GAGs solution
volume) were encapsulated in the fibers (2% HA with 1% heparin and double strength collagen
at 2 mg/ml concentration). To form a bundle of fibers, the fibers were wrapped around a stainless
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steel rod that was attached to a rotating motor at fixed speed of 30 cm/min. The bundle was then
washed with 0.9 wt% NaCl, stabilized with 0.1 wt% PGA solution, and washed again with 0.9
wt% NaCl. The wrapping was performed in a certain procedure: wrap the first layer at certain
angle and the second layer at the opposite angle and hence ensure a porous scaffold will form
(Fig. 53).
The seeded bundle scaffold was then processed for histology and H&E staining.

Figure 53: Fiber bundle fabrication method. Schematic diagram of bundle scaffold fabrication process of
hepatocytes encapsulated in 2 % HA + 1% heparin + double strength collagen.
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7.3

Results

7.3.1

Membrane Thickness for Different Formulas of GAG-Chitosan Polyelectrolyte

Complex Fibers
The phase contrast imaging observations were summarized in the table below (table 7)
with noticeable remarks for each formula. 2% HA with 1% heparin and double strength collagen
formed the thickest membrane with fibers that didn’t snap while formation and stayed as
continuous fibers which made them easy to handle. The dehydrated fibers membranes were very
thin (Fig. 54.A) with thickness of about 1 µm (Fig. 54B). We can notice here that the membranes
have smooth surface from inside and rough surface from the outside, as the chitosan acting with
the GAG from outside and building up towards the outside.

1% heparin

0.5%
heparin

No heparin

8%CSA+3%CMC+
double strength collagen
(2mg/ml neutralized)
•
•
•
•
•
•

Continuous fibers.
While washing
rupture.
Thin walls
Snapping
Rupture
Thin walls

•
•

Snapping
Moderate thickness

8% CSA +2%HA+
double strength
collagen (2mg/ml
neutralized)
• Snapping.
• Very thin walls

2%HA+ double
strength collagen
(2mg/ml neutralized)
•
•

Snapping
Very thin walls

•
•

Continuous fibers
Moderate thickness

•
•

Continuous fibers
Very thin walls

•
•

Continuous fibers
Very thin walls

•

Continuous fibers no
snapping.
Easy to handle
Thick walls

•
•

Table 7: Summary of observations for fibers made from different GAG formulations.
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The fiber membranes formed with this technique have porous network as seen via
scanning electron microscope (Fig 54C & D); this will allow small molecules to pass through the
membranes in and out the fibers but in the same time provide means of protection against flow.
This architecture resembles the space of Disse at the hepatic sinusoids. The inside pores were in
the range of 119.6 ± 24 nm diameters (Fig. 54C) and the outside pores were in the range of 178.3
± 33 nm diameters (Fig. 54D) as estimated using ImageJ (Feret diameter).
A

B

Inside surface

Outside surface

C

D

Figure 54: SEM photos of the fiber’s membrane. (A and B) is an edge of a fiber membrane. The
membranes have high porosity from inside (C) and outside (D).

When fixed hepatocytes were encapsulated in the 2% HA with 1% heparin and doublestrength collagen, and then flattened by crushing them under glass cover slip, the wall thickness
was 25.90 ± 9.87 µm (Fig. 55A&B), while the dehydrated membranes had thickness of ~ 1 µm
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(as seen via SEM images Fig. 54A). This is in agreement with the fact that the membranes were
basically hyrogels with water as the main content.
We can see from the SEM images (Fig. 55C&D) that the fixed cells were connected to
each other with the ECM material used in the encapsulation (collagen) which will provide the
basic ECM from the start of the culture until the live cells secrete their own ECM material. This
is of high importance for anchorage-dependent cell types like hepatocytes.
For the other formulations, the walls were very thin to be measured for wall thickness.
Even at high magnification, the edges of the walls can’t be focused properly to distinguish the
start and the end of the membrane wall. The other formulations tested either formed thin-walled
capsules, or very fragile (snapping), or were rupturing while washing out the excess polymer, or
a combination of these remarks. Figure 57 lists phase contrast images for each formulation
tested.
A

B

C

D

Figure 55: Phase contrast images (A&B) and SEM images (C&D) of encapsulated hepatocytes in
chitosan- 2% HA with 1% heparin and double strength collagen fibers.
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Figure 56: Phase contrast images illustrating the membranes formed in each of the listed formulations.

7.3.2

Encapsulated Hepatocytes (with and without MSCs) Morphology
The cells aggregated into large cylindrical aggregates (following the shape of the fibers)

that were floating inside the fibers. They aggregated as one big aggregate in monocultures (Fig.
57A & B). In the heterotypic cultures, they appeared as several smaller separate aggregates (Fig.
57C&D). The fibers were about 0.65 ± 0.13 mm thick.
A

B

114
B

C

D

Heterotypic culture

Monotypic culture

A

Figure 57: Phase contrast images of encapsulated hepatocytes in chitosan- 2% HA with 1% heparin and
double strength collagen fibers. (A & B) Monotypic cultures, (C & D) Heterotypic cultures.

While the fibers looked intact, were easy to handle, and survived the washing and
shaking steps on the fabrication day (Fig. 58A), they swelled on day 2 (Fig. 58B) and eventually
ruptured and released all aggregates by day 4 of culture (Fig. 58C).
A

B

C

Figure 58: Digital images of encapsulated hepatocytes in chitosan- HA- heparin fibers. Digital color
images of the fibers on (A) day 1, (B) day 2, and (C) day 4.
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7.3.3

Metabolic Performance of Encapsulated Hepatocytes with/without MSCs
No statistically significant differences in urea secretion between cultures of encapsulated

hepatocytes only and cultures of mixed hepatocytes and MSCs. The urea secretion rates were at
depressed rates compared to collagen gel sandwich controls (Fig. 59A). On the other hand, no
albumin detected at all in both cultures (Fig. 59B).
Urea Secretion
2%HA, 1% Heparin, Double strength collagen

A
3.5

5

Rate (ug/hr/million cells)

Double Gel Sandwich
Hepatocytes Only
MSCs and Hepatocytes

3.0

Rate (ug/hr/million cells)

Albumin Synthesis
2%HA, 1% Heparin, Double strength collagen

B

2.5

2.0

1.5

1.0

Double Gel Sandwich
Hepatocytes Only
MSCs and Hepatocytes

4

3

2

1

0.5

0

0.0
0

1

2

3

4

5

6

7

0

Day in Culture

1

2

3

4

5

6

7

Day in Culture

Figure 59: Metabolic performance of monotypic and heterotypic cells suspension in chitosan- 2% HA
with 1% heparin and double strength collagen fibers. (A) Urea, and (B) albumin secretion rates.

7.3.4

Cell Distribution in Fiber Bundle Scaffold
Fibers could not be easily wrapped around the connector and form a bundle of fibers in

the intended way of wrapping procedure illustrated in figure 53 above. Instead, they wrap around
each other at a concentric bundle dragging the whole scaffold downward (Fig. 60). The wrapping
was performed to generate the required spacing between the fibers by moving the wrapping rod
up and down. Histology images revealed that the fibers have spacing between them inside the
bundle (porous scaffold) (Fig. 61 black arrows), but it looks like there was a membrane at the
periphery sealing the whole bundle (Fig. 61 red arrows).
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Figure 60: Digital image of fixed hepatocytes in fiber bundle scaffold.

Figure 61: Cell distribution and fibers architecture in a wrapped bundle. (Left) H&E histology image of
a whole cross sectional area for fixed hepatocytes in fiber bundle scaffold. (Right) phase contrast images
of the fibers bundle.
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7.4

Discussion
The hyaluronic acid based fibers makes a promising approach in the field of modular

tissue engineering. They form thick membranes, easy to handle and elastic fibers which make
them of a better choice among other GAGs; e.g. chondroitin sulfate A. The major challenge with
the fiber system presented in this work was the ruptures of the fibers, where they lose their
contents rapidly even in static culture. The depressed metabolic functions seen were due to the
loss of the aggregates during media changes. Albumin was not detected because it is considered
to be a relatively large protein (MW about 67,000 Da) that may have not diffused from the
aggregates through the membranes walls and into the medium. V. Lin and H. Matthew, 2002
[121] calculated effective diffusivity for albumin to be the lowest among other materials that
have lower molecular weights.
Fibers with diameters higher than 500 µm will generate aggregates of the same diameters
and those are known to develop necrotic centers

as they will experience mass transfer

limitations of metabolites and oxygen in the core [91]. An automated system of pulling the
fibers at a speed that was less or equal to the extruding rate was required to ensure the minimum
diameter possible to reach; thinner fibers are preferred as there will be more material to carry a
given volume load. Another important parameter was the architecture of fiber wrapping that will
play significant role in overall strength of the loaded scaffold.
As the remaining GAG solution may stay inside the fibers (GAG molecules that are not
incorporated to the walls by reacting with chitosan molecules); the water molecules will diffuse
through the fibers membrane into the fibers interior causing them to swell and eventually
rupture. Reducing the internal content of GAG by incorporating other particles to the interior
will be a possible solution to the rupture problem. Currently, other students in our lab are
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investigating these alternatives; e.g. adding chitosan microcarriers or collagen microcarriers to
the microcapsules and fibers interiors.

7.5

Conclusions and Future Work
•

Thinner fibers are better to use (should be <300µm); ensure no mass transfer limitations
and more material to carry a given volume load.

•

The architecture of fiber wrapping plays significant role in overall strength of the loaded
scaffold.

•

High porous scaffolds with high cell densities can be achieved using the fiber wrapping
system. The fiber bundles can be also perfused in the bioreactor system once the fiber
rupturing problem is addressed.

•

Enforcing the fibers membranes with chitosan microfibers to enhance their mechanical
strength might be a valid solution for the issues faced in this work.

•

Further modifications to the interior of the capsules are needed in order to minimize the
GAGs content and hence eliminate the rupture issue. Incorporating chitosan microcarriers
or collagen microcarriers to the interior environment of the fibers will help decreasing the
GAG content.
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In vitro assembly of functional liver tissue is needed to enable the transplantation of
tissue-engineered livers. In addition, there is an increasing demand for in vitro models that
replicate complex events occurring in the liver. However, tissue engineering of sizable
implantable liver systems is currently limited by the difficulty of assembling three dimensional
hepatocyte cultures of a useful size, while maintaining full cell viability, an issue which is
closely related to the high metabolic rate of hepatocytes. In this study, we first compared two
designs of highly porous chitosan-heparin scaffolds seeded with hepatocytes in dynamic
perfusion bioreactor systems. The aim was to promote cell seeding efficiency by effectively
entrapping 100 million hepatocytes at high density. We found that scaffolds with radially
tapering pore architecture had highly efficient cell entrapment that maximized donor hepatocyte
utilization, compared to alternate pore structures. Hepatocytes showed higher seeding efficiency
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and metabolic function when seeded as single cell suspensions as opposed to pre-formed, 100µm
aggregates. Seeding efficiency was found to increase with flow rate, with single cell and
aggregate suspension exhibiting different optimal flow rates. However, metabolic performance
results indicated significant shear damage to cells at high efficiency flow rates. To better
maintain hepatocyte basement membrane and cell polarity, spheroid co-cultures with
mesenchymal stem cells (MSC) were investigated. Hepatocytes and MSCs were seeded in three
different architectures in an effort to optimize the spatial arrangement of the two cell types. MSC
co-culture greatly enhanced hepatocyte metabolic function in agitated cultures. Interestingly, the
effects of diffusion limitations in spheroid culture, coupled with shear damage and subsequent
removal of outer hepatocyte layers produced a defined oscillation of urea production rates in
certain co-culture arrangements. A mathematical model of urea synthesis in shear-exposed, coculture spheroids reproduced the metabolic oscillations observed. This result together with
culture observations suggests that MSCs can provide both physiological support and some direct
shear protection to hepatocytes in perfused or shear-exposed culture environments. Finally, in
order to reduce hepatocyte exposure to excessive shear forces in perfused scaffolds, a modular
scaffold design based on polyelectrolyte fiber encapsulation was explored. Scaffolds with
uniformly distributed, shear protected cells were achieved.
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